Preparation and application of porous framework materials for bio-separation
Abstract
Efficient and precise bioseparation is essential and increasingly urgent for advancing life sciences and biotechnology. This demand is amplified by precision medicine, which requires isolating, enriching, characterizing and utilizing low-abundance, complex biomolecules, including post-translationally modified peptides, proteins and metabolites. Conventional separation techniques are unable to handle this challenge, which results in significant bottlenecks in the development of targeted drugs, biomarker discovery, and individualized therapeutic monitoring. Porous framework materials offer transformative solutions via structural tunability, ultrahigh surface areas and tailor-made pore chemistries: metal–organic frameworks (MOFs) enable selective protein separation and modified peptide enrichment through hydrophilic/metal coordination interactions, covalent organic frameworks (COFs) minimize protein denaturation with high stability and modifiable surfaces, and hydrogen-bonded organic frameworks (HOFs) achieve gentle, efficient aqueous biomarker enrichment via intrinsic biocompatibility and dynamic hydrogen bonding. This review systematically classifies MOFs, COFs, and HOFs and summarizes their applications in the separation and analysis of small-molecule drugs, phosphopeptides, glycopeptides, and proteins. We also discuss the key challenges, including pre- and post-modification methodologies, the construction of chiral porous materials, and integration with magnetic microspheres. Finally, we highlight their future prospects in advancing bioseparation for precision medicine, diagnostics, and therapeutic development, driving progress across biotechnology and biomedical engineering.
Keywords
INTRODUCTION
Importance and urgency of bioseparation
In the context of rapid advancements in life sciences and biotechnology, bioseparation has emerged as a crucial bridge[1-3]. Efficient and precise bioseparation technologies are indispensable for ensuring the quality, safety, and efficacy of bioproducts - ranging from the extraction of high-purity bioactive compounds from natural sources to the large-scale production of genetically engineered therapeutics[4,5]. With growing global demands for innovative pharmaceuticals[6], sustainable biomaterials[7-9] and functional green foods[10], the complexity of biological samples has significantly increased. This complexity, coupled with the urgent need to isolate low-abundance[11], high-value biomolecules (e.g., post-translationally modified peptides) from highly intricate matrices, emphasizes the limitations of conventional separation methods[12]. Consequently, overcoming these bottlenecks through next-generation separation platforms is not only crucial for advancing biotechnological innovation[13] but also essential for addressing pressing challenges in human health[14] resource sustainability[15] and environmental protection[16].
To meet these diverse separation challenges, porous materials have emerged as transformative tools due to their exceptional structural and chemical tunability[17-20]. Their high specific surface area[21-23], controllable pore architecture[24-26], and customizable surface functionality[27-29] make them uniquely suited for both macromolecular (e.g., proteins, nucleic acids, viruses)[30,31] and small-molecule (e.g., metabolites, drug candidates, signaling molecules)[32-34] separations from complex biological environments. For macromolecules, the well-defined pore size and surface charge of porous frameworks enable size-exclusion effects and electrostatic interactions, facilitating high-resolution separation and enrichment of target biomacromolecules. In contrast, for small molecules, the designable pore chemistry and host–guest recognition capabilities allow selective adsorption based on polarity, hydrogen bonding, or π–π interactions - critical for isolating trace bioactive compounds or removing toxic impurities. This dual capability positions porous materials as universal platforms capable of addressing the full spectrum of bioseparation needs, from proteomics and genomics to metabolomics and pharmaceutical purification.
Among these advanced porous platforms, metal–organic frameworks (MOFs), covalent organic frameworks (COFs), and hydrogen-bonded organic frameworks (HOFs) represent a powerful triad of functional materials, each offering distinct yet complementary advantages. MOFs feature highly tunable pore environments and abundant metal-coordination sites, enabling precise recognition and efficient adsorption of biomolecules[35,36] based on size, charge, and affinity. This makes MOFs particularly effective in discriminating structurally similar species - a persistent challenge in traditional chromatography. COFs, built from strong covalent linkages, exhibit exceptional chemical and thermal stability, along with ordered porous structures and easily modifiable pore surfaces[37-40]. These features allow COFs to maintain integrity under harsh conditions while facilitating selective interactions through tailored functional groups, thereby enhancing separation selectivity and reusability. More recently, HOFs have gained attention for their mild synthesis conditions, intrinsic biocompatibility, and dynamic yet directional hydrogen-bonding networks[41-43]. These characteristics not only facilitate easy processability and recyclability but also enable selective binding of polar biomolecules, making HOFs especially promising for aqueous-phase separations and bio-related applications. Notably, all three frameworks share ultra-high surface areas and potential for regeneration, significantly improving separation capacity per unit volume while reducing operational costs and environmental footprint. Together, MOFs, COFs, and HOFs are driving a paradigm shift in bioseparation - transforming it from a bottleneck into a high-performance, sustainable, and intelligent process capable of handling both macromolecular complexity and small-molecule precision.
Key parameters for the development of porous materials for bioseparation
Porous materials like MOFs, COFs, and HOFs have emerged as pivotal tools in the field of bioseparation due to their high specific surface areas[44], tunable pore structures, and versatile surface functionalities. Their ability to achieve precise molecular sieving through size-exclusion effects, coupled with selective interactions facilitated by surface modifications, makes them ideal candidates for various biological separations. This section highlights the development trajectory of these materials and their application potential in bioseparation.
Several critical attributes contribute to the rapid progress of porous materials in bioseparation: 1. Tunable Pore Structures: The adjustable pore sizes enable efficient separation based on the dimensions of biomolecules ranging from small metabolites to large macromolecular complexes. 2. Surface Functionalization Flexibility: The grafting of diverse functional groups allows for selective interactions with target biomolecules via mechanisms such as hydrogen bonding and electrostatic adsorption. 3. Chemical/Thermal Stability: Robust stability ensures that these materials maintain their structural integrity under various biological conditions. 4. Morphological Versatility: Innovations in synthesis methods, including 3D printing[45] and hierarchical assembly[46,47], allow for the creation of different forms suitable for a range of separation platforms. 5. Biocompatibility and Stimuli Responsiveness: Modifications can enhance biocompatibility[48,49] while stimuli-responsive properties[50,51] enable dynamic control over separation and release processes.
Although MOFs, COFs, and HOFs all show great potential in bioseparation, they differ significantly in structure, stability, and functionality. MOFs offer high porosity and tunable metal–ligand interactions but often suffer from limited hydrolytic stability; COFs feature robust covalent frameworks and precise pore engineering yet can be challenging to process; HOFs exhibit excellent biocompatibility and reversible assembly but generally have lower mechanical strength and narrower pore size distributions. A concise comparison of their advantages, disadvantages, and representative bioseparation applications is provided in Table 1, offering practical guidance for material selection under specific separation requirements.
Comparative overview of MOFs, COFs, and HOFs in bioseparation, summarizing their key advantages, limitations, and representative applications
| Type | Advantages | Disadvantages | Application |
| MOFs | High specific surface area Tunable pore size Easy functionalization Modification | Insufficient chemical stability in aqueous phase and biological environment | For the efficient enrichment, separation, and purification of target biomolecules |
| COFs | Chemical stability High selectivity High adsorption capacity | Synthetically challenging | For high-precision separation of large biomolecules |
| HOFs | Mild synthetic conditions High reusability Excellent biocompatibility | Chemical instability | For biocompatible separation of small-molecule drugs |
Brief introduction of applications of porous materials in bioseparation
In protein separation, MOFs leverage moderate pore environments and surface charge control to achieve selective adsorption and separation of proteins, such as enzymes[30,52]. COFs minimize protein denaturation during adsorption through hydrophilic pores and inert surfaces, making them suitable for purifying large molecules like antibodies. HOFs, with their unique hydrogen-bonding networks, offer excellent solution processability and biocompatibility, ideal for gentle handling and enrichment of proteins.
In glycopeptide enrichment, MOFs enhance hydrophilic interactions by introducing amino, carboxyl, or hydroxyl groups on their surfaces, facilitating stronger binding with glycan chains[53]. Additionally, metal sites within MOFs can form coordination bonds with the hydroxyl groups of glycopeptides. COFs achieve strong hydrophilicity and high affinity for glycopeptides through the introduction of functional groups like polyethyleneimine (PEI) and boric acid. HOFs utilize specific hydrogen-bonding patterns to achieve efficient recognition and enrichment of glycopeptides, particularly in aqueous media.
For phosphopeptide enrichment, metal nodes in MOFs or post-modified metal ions interact with phosphate groups to form stable chelates. Polar pores in MOFs facilitate adsorption via hydrogen bonding or electrostatic interaction[54]. COFs primarily use introduced metal sites to form coordination bonds with phosphate groups or achieve specific binding through electrostatic attraction between functionalized groups and phosphorylated peptides. HOFs, with their inherent hydrophilicity and modifiable pore environments, show promise for enriching phosphopeptides and enhancing selectivity through rational functionalization.
In summary, MOFs, COFs, and HOFs have emerged as transformative platforms in bioseparation, offering structurally programmable frameworks[55], well-defined porosity[56-58], and tunable interfacial functionalities[59,60] that surpass the limitations of conventional materials. These attributes not only address long-standing challenges in selective recognition and efficient separation within complex biological matrices but also enable a shift from passive adsorption toward intelligent, stimuli-responsive, and multifunctional separation systems. In this review, we systematically examine the recent advances of these porous framework materials in key bioseparation applications - particularly in the selective separation of proteins and the high-efficiency enrichment of glycopeptides[61,62] and phosphopeptides[63,64]. We further highlight cutting-edge developments in stimuli-responsive separation platforms, biomimetic recognition interfaces, and synergistic purification strategies. A comparative analysis of performance across different material systems is provided, along with discussions on current challenges including stability under physiological conditions, scalability, pre- and post-modification, and biocompatibility. Finally, we offer perspectives on future directions, emphasizing their potential in precision medicine and high-throughput biomolecular separation and analysis.
In order to provide experimental support and theoretical guidance for the design of high-performance separation materials, this study methodically clarifies the synergistic regulation mechanism of pore geometric characteristics and local chemical microenvironments of porous framework materials (including MOFs, COFs, and HOFs) on the biomolecule separation performance. Based on the correlation between key structural parameters (e.g., pore size, functional group type, and charge distribution) and separation performance parameters (e.g., selectivity and adsorption capacity) established in this study, the development of standardized machine learning datasets and the further expansion of data-driven methods for the rational design of bioseparation materials are anticipated to emerge as a highly promising research direction in this field.
APPLICATION OF MOFS IN BIOSEPARATION
MOFs are a promising multifunctional crystalline material which are constructed through the self-assembly of metal ions/clusters and organic ligands via coordination bonds. These materials has intrinsic characteristics such as high specific surface area[65,66], tunable pore size distribution[67,68], regular nanoscale cavity structure[69,70], diverse topological configurations[71,72], and excellent chemical stability[73,74] Owing to their unique structural and functional properties, MOFs exhibit great application potential in many fields including glycopeptide enrichment[75,76], phosphopeptide enrichment[77-79], and protein separation[80-82]. Therefore, it provides a powerful material platform for the precise enrichment and analysis of low-abundance biomolecules in complex biological samples.
Separation of chiral molecules
Chirality, as a fundamental property of nature, plays a primary role in life activities and pharmaceutical research[83,84]. Approximately 40%-50% of drugs exist in the form of chiral molecules, and their enantiomers often show significant differences in biological activity, one enantiomer may possess the expected pharmacological effects, whereas the other may be accompanied by loss of activity, toxicity, or adverse effects. These differences directly affect the therapeutic effects and safety of drugs. Therefore, efficient separation of chiral compounds has become a critical technical bottleneck in the screening of bioactive molecules, drug synthesis, and quality control[85,86]. In the field of separation science, owing to their unique enantiomeric recognition and separation capabilities, chiral MOFs have demonstrated significant technical advantages, becoming a frontier hotspot in the research of chiral separation materials.
In 2020, Yu et al. reported the application of D-his-ZIF-8@SiO2 core-shell microspheres as a chiral stationary phase (CSP) for the enantio-separation in high-performance liquid chromatography (HPLC), demonstrating high enantio-selectivity and effective chemo-selectivity[87]. Figure 1A is the schematic diagram of the preparation process for D-his-ZIF-8@SiO2. The structural and morphological properties of ZIF-8@SiO2 nanocrystals were characterized using powder X-ray diffraction (PXRD), scanning electron microscope (SEM), and Fourier transform infrared spectroscopy (FT-IR). PXRD patterns [Figure 1B] confirmed that the synthesized D-his-ZIF-8 nanocrystals showed characteristic diffraction peaks consistent with pristine ZIF-8, indicating their structural similarity. The coexistence of distinct signals from SiO2−COOH and D-his-ZIF-8 in the spectra validated the successful formation of D-his-ZIF-8 on the SiO2 microspheres. SEM was applied to characterize the morphological features of SiO2−COOH, D-his-ZIF-8 nanocrystals, and D-his-ZIF-8@SiO2 core-shell microspheres [Figure 1C]. The SiO2−COOH microspheres demonstrated a smooth surface topography with an average diameter of approximately 5 mm. In contrast, the synthesized D-his-ZIF-8 nanocrystals displayed uniform polyhedral shapes with an average particle size of 200 nm [Figure 1C]. For the D-his-ZIF-8@SiO2 core-shell structure, the average diameter increased from 5 mm (naked SiO2 microspheres) to 5.5 mm, providing direct evidence for the successful immobilization of D-his-ZIF-8 nanocrystals onto the SiO2 microsphere surface. the successful synthesis of the D-his-ZIF-8@SiO2 core-shell structure was further confirmed by FT-IR analysis [Figure 1D]. As shown in Figure 1E, the homochiral structure of D-his-ZIF-8 was characterized by circular dichroism (CD) spectroscopy, compared with ZIF-8, a clear positive dichroic signal appeared at 235 nm, indicating that the chiral ligand was successfully embedded in the ZIF-8 framework through self-assembly of Zn2+, 2-methylimidazole, and d-histidine as chiral ligands. To evaluate the enantioselective separation capability of D-his-ZIF-8@SiO2, 18 pairs of racemic compounds, including 1-(1-naphthyl)ethanol, 1-(4-chlorophenyl)ethanol, 1,1′-bi-(2-naphthol), 3,5-dinitro-N-(1-phenylethyl)benzamide, praziquantel, zopiclone, and flurbiprofen, naproxen, were resolved on the material-packed column using binary mobile phases of n-hexane and isopropanol at different volume ratios (99:1, 95:5, 9:1, 8:2, v/v). Table 2 summarizes the chromatographic parameters obtained from the column, including retention factor (k), separation factor (α), and resolution (Rₛ). For the racemates tested, the corresponding chromatograms of these racemic mixtures appearing in Figure 1F-H showed excellent enantiomer separation. Compared to the commercial AD column (Daisel Corp.), the D-his-ZIF-8@SiO2 column offered complementary resolution for these racemic compounds.
Figure 1. (A) Schematic demonstration for the preparation of D-his-ZIF-8@SiO2 core−shell microspheres; (B) Comparison of PXRD patterns of the prepared SiO2−COOH, D-his-ZIF-8, and D-his-ZIF-8@SiO2; (C) SEM image of D-his-ZIF-8@SiO2; (D) FT-IR spectra of SiO2, SiO2−COOH, D-his-ZIF-8, and D-his-ZIF-8@SiO2 core−shell microspheres; (E) CD patterns of ZIF-8 (red) and D-his-ZIF-8 (black); (F-H) HPLC chromatograms on the D-his-ZIF-8@SiO2 column (column A, 25 cm length × 2.1 mm i.d.) for the separation of racemic compounds: trans-stilbene oxide (F), praziquantel (G), and 1-(1-naphthyl)ethanol (H). (A-H) are reprinted with permission from Ref.[87], Copyright © 2023 by American Chemical Society. PXRD: Powder X-ray diffraction; SEM: scanning electron microscope; FT-IR: Fourier transform infrared spectroscopy; CD: circular dichroism; HPLC: high-performance liquid chromatography.
Separations of racemic compounds on a D-his-ZIF-8@SiO2-packed column
| Serial number | Racemate | Mobile phase n-hexane/isopropanol (v/v) (column A) | Retention factor (κ) (column A) | Separation factor (α) | Resolution (Rs) (column A) | |
| Column a | Column b | |||||
| 1 | 1-(1-Naphthyl)ethanol | 9:1 | 0.35 | 7.13 | 3.74 | |
| 2 | Benzoin | 99:1 | 0.73 | 5.70 | 1.26 | 2.33 |
| 3 | Praziquantel | 9:1 | 0.50 | 3.29 | 1.17 | 2.14 |
| 4 | 1,1′-Bi-(2-naphthol) | 9:1 | 0.711 | 3.96 | 2.31 | |
| 5 | 1-(4-Chlorophenyl)ethanol | 95:5 | 0.84 | 1.77 | 1.04 | 1.23 |
| 6 | Hydrobenzoin | 99:1 | 0.38 | 2.35 | 1.08 | 1.04 |
| 7 | Trans-stilbene oxide | 9:1 | 3.64 | 1.15 | 2.69 | 1.65 |
| 8 | Warfarin | 8:2 | 0.47 | 2.38 | 3.84 | 1.28 |
| 9 | Naproxen | 95:5 | 0.79 | 7.55 | 3.53 | |
| 10 | Flurbiprofen | 9:1 | 3.31 | 1.20 | 1.47 | 1.16 |
| 11 | 1-(9-Anthryl)-2,2,2-trifluoroethanol | 95:5 | 0.87 | 4.03 | 1.38 | 2.33 |
| 12 | 3,5-Dinitro-N-(1-phenylethyl)benzamide | 9:1 | 0.50 | 1.99 | 1.27 | 1.00 |
| 13 | Zopiclone | 8:2 | 0.47 | 6.74 | 2.24 | |
| 14 | Salbutamol | 99:1 | 0.40 | 2.26 | 1.01 | |
| 15 | Ibuprofen | 95:5 | 0.55 | 1.85 | 0.69 | |
| 16 | Alprenolol | 9:1 | 3.66 | 1.33 | 1.5 | 0.62 |
| 17 | Metoprolol | 95:5 | 0.24 | 2.62 | 0.99 | |
| 18 | Ketoprofen | 95:5 | 0.57 | 1.77 | 1.17 | 0.64 |
However, it is widely recognized that pure MOFs-packed HPLC columns suffer from high backpressure due to the small sizes of the MOF particles and their inner pores, which significantly hinder their practical applications in HPLC chiral separations. To tackle these difficulties, Yu et al. utilized silica gel as the substrate to prepare a novel chiral core-shell composite [Zn2(D-Cam)2(4,4′-bpy)]n@SiO2, which was employed as a stationary phase for column packing[87]. This composite-packed column not only effectively mitigated the issue of excessive column pressure but also significantly improved chiral separation efficiency. The developed stationary phase exhibits satisfactory separation performance toward disubstituted benzene isomers and a variety of chiral compounds, including alcohols, amines, ketones, esters, epoxides, and alkaloids, enabling highly efficient HPLC-based enantioseparation [Figure 1F-H].
Furthermore, Yuan’s group has carried out chromatographic separations using various chiral MOFs as CSPs, including [Cu(S-mal)(bpy)]n][88], [{[Cu(sala)][89], Cu(S-mal)(bpe)]n[90], [Co2(D-cam)2(TMDPy)]@SiO2[91] and [Zn(L-tyr)]n(L-tyrZn)[92].
Enrichment of peptides
Enrichment of glycopeptide
Protein glycosylation, a highly prominent and diverse post-translational modification (PTM), significantly alters protein functions and profoundly influences multiple biological activities[93]. Variations in protein glycosylation can govern inflammatory responses, allow viruses to evade immune detection, facilitate dissemination of cancer cells, and modulate programmed cell death[94]. To understand the processes of protein glycosylation within complex biological systems, efficient enrichment and selective analysis of glycopeptides is essential. However, the complexity of biological sample matrices, low abundance of glycopeptides, and diversity of glycan structures together comprise core technical bottleneck in glycoproteomics research. As a result, the specific enrichment of glycopeptides is essential for their accurate analysis. Research showed that MOFs with strong hydrophilicity displayed meaningful advantages in the efficient capture of glycopeptides[95].
For example, Zhou et al. developed a novel dual-hydrophilic MOF material based on UiO-66, which exhibited significantly enhanced hydrophilicity and excellent hydrophilic interaction chromatography (HILIC) enrichment performance for glycopeptide analysis[96]. The synthesis procedure is shown in Figure 2A. As shown in Figure 2B, all 2θ characteristic peaks in PXRD pattern of modified UiO-66 MOF are consistent with those of the parent UiO-66-NH2 reported in literature[97]. FT-IR further confirmed the successful modification of boronic acid and phosphate functional groups on UiO-66 MOF [Figure 2C]. MOF was characterized by transmission electron microscope (TEM) [Figure 2D], and these nanoparticles (NPs) exhibited uniform shapes and their topological structures were comparable to those of unmodified UiO-66 MOF. The above results jointly confirmed the successful preparation of postmodified UiO-66 MOF. To evaluate the glycopeptide enrichment performance and reusability of the UIO-PBA&FDP material, 100 μg of this material was used to conduct glycopeptide enrichment experiments on a 100 fmol/μL immunoglobulin G (IgG) digest, with a total of 3 repeated cycles. The results are presented in Figure 2E. Experimental results demonstrated that the UIO-PBA&FDP probe could effectively capture glycopeptides. Even after 3 repeated uses, the enriched glycopeptides still exhibited high signal intensity and signal-to-noise (S/N) ratio, which confirmed that the UIO-PBA&FDP material possesses favorable reusability. The complementarity and overlap of the three distinct approaches to N-glycopeptide identification are graphically depicted in this Venn diagram. The UIO-PBA&FDP method showed the highest recognition ability, while the parts commonly identified by the three methods represent the most reliable results [Figure 2F]. This WebLogo describes the amino acid sequence features surrounding the N-glycosylation sites identified under specific conditions (UIO-PBA&FDP). When enriching N-glycopeptides, the UIO-PBA&FDP method can effectively recognize glycosylation sites that adhere to the traditional N-X-S/T motif. The preference for amino acids in the vicinity provides additional insights into the selectivity of N-glycosylation sites, which is conducive to understanding the sequence specificity during the glycosylation process [Figure 2G]. The highly hydrophilic UIO-PBA&FDP, demonstrated high-sensitivity enrichment of N-linked glycopeptides with a detection limit of 0.5 fmol/mL. The innovation of this material is that PBA&FDP’s hydrophilic design, The hydrophilic design of PBA&FDP is achieved by introducing boronic acid groups at the ligand termini and modifying FDP with metal sites, thus creating a MOF interface that is both synergistically functionalized at both ends and highly hydrophilic, which in turn efficiently drives the HILIC-based enrichment of glycopeptides. Specifically, 359 N-linked glycopeptides corresponding to 104 glycoproteins were verified from only 1 mL of human serum, illustrating its superior enrichment performance for glycopeptides and analysis by UIO-PBA&FDP from biological sample.
Figure 2. (A) Post-modification of UIO-PBA&FDP and the procedure of HILIC enrichment for glycopeptides and analysis from biological Sample; (B-D) XRD patterns, FT-IR spectra and TEM image of as-synthesized UIO-PBA&FDP; (E) MALDI-TOF MS of peptide mixtures of 100 fmol/μL tryptic digests of IgG with enrichment by UIO-PBA&FDP for 3 cycles. The red stars represent glycopeptides; (F) Venn diagram showing the overlapping of unique glycosylated peptides; (G) The motif analysis of glycosylation sites identified from human serum after enrichment by UIO-PBA&FDP. (A-G) are reprinted with permission from Ref.[96], Copyright © 2023 by Springer Nature. HILIC: Hydrophilic interaction chromatography; XRD: X-ray diffraction; FT-IR: Fourier transform infrared spectroscopy; TEM: transmission electron microscope; MALDI-TOF MS: matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; IgG: immunoglobulin G.
Based on the molecular size and hydrophilic properties of glycopeptides, ideal enriched materials for biological samples must have suitable pore structures and highly hydrophilic surfaces. MOFs emerge as promising candidate materials in this context, nonetheless, their practical applications are frequently impeded by inherent constraints, including small micropore sizes and inadequate chemical stability. In response to the above challenges, Pu et al. developed an innovative strategy to combine collaborative etching with surface functionalization processes and introduce phytic acid (PA) to construct hydrophilic mesoporous MOFs[98]. Furthermore, by introducing polyvinylpyrrolidone (PVP) during MOF synthesis, the modified metal organic framework material exhibited extremely high stability [Figure 3A]. TEM, FT-IR, SEM, and X-ray photoelectron spectroscopy (XPS) were used to confirm the successful synthesis of material [Figure 3B-G]. In particular, Figure 3E is intended to illustrate the effect of surface modification on the zeta potential of the material more precisely, it demonstrates that the zeta potential of Ce-MOF shifts from positive to negative after the introduction of a PA, which affects the subsequent glycopeptide enrichment. The etching process can control the pore size well and is suitable for glycopeptide enrichment. The as-prepared PA-modified cerium-based MOFs feature expanded hydrophilic mesoporous channels, thereby endowing Ce-MOF@PA with superior glycopeptide enrichment performance. Figure 3H and I describe the efficient performance of Ce-MOF@PA nanocomposites in glycopeptide enrichment. Before enrichment, only one glycopeptide with low mass spectral intensity was detected, and non-glycopeptides dominated the mass spectrometry spectrum. After capture with Ce-MOF@PA, 39 non-interfering glycopeptides were clearly detected, and the signal intensity of glycopeptides was significantly enhanced. Specifically, 422 glycopeptides were selectively captured from 2 mL of trypsin-digested human serum, which contains 155 glycoprotein [Figure 3J and K].
Figure 3. (A) Schematic illustration of the synthesis of Ce-MOF@PA and the enrichment procedure of glycopeptides; (B) XPS survey spectra of Ce-MOF@PA; (C) High-resolution XPS measurements of P2p for Ce-MOF@PA; (D) The FT-IR spectra of Ce-BTC, Ce-MOF, and Ce-MOF@PA; (E) Zeta potential of Ce-BTC, Ce-MOF, and Ce-MOF@PA; (F and G) SEM and TEM images of Ce-MOF@PA; MALDI-TOF MS of IgG digests (6 μg) (H) before enrichment and after enrichment by (I) Ce-MOF@PA. The peaks of glycopeptides are marked with “In”; Overlapping of identified (J) glycopeptides and (K) glycoproteins in human serum after enrichment by Ce-MOF@PA and commercial HILIC material. (A-K) are reprinted with permission from Ref.[98], Copyright © 2019 by American Chemical Society. MOF: Metal–organic framework; PA: phytic acid; XPS: X-ray diffraction; FT-IR: Fourier transform infrared spectroscopy; SEM: scanning electron microscope; TEM: transmission electron microscope; MALDI-TOF MS: matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; IgG: immunoglobulin G; HILIC: hydrophilic interaction chromatography.
Enrichment of phosphopeptides
Among the diverse regulatory mechanisms of organisms, protein phosphorylation is one of the most universal mechanisms. Studies have confirmed that it is associated with cell signaling and communication, cell proliferation, differentiation, survival and homeostasis maintenance, whereas regulating protein degradation, translation, transcription and metabolic processes[99]. Although Phosphorylated proteins are extensively found in all cells of organisms and are essential to life activities, their natural abundance is usually low[100]. This problem can only be solved by efficient enrichment and separation techniques in analytical methods such as mass spectrometry.
He et al. produced Zr-MOF in situ on the surface of Ti3C2Tx in an open glass tube using dielectric barrier discharge (DBD) technology[101]. During the growth of Zr-MOF, Ti3C2Tx was simultaneously oxidized by DBD, resulting in the formation of TiO2 NPs on its surface. Oxid-Ti3C2Tx/UIO-66-NH2 composites were also prepared [Figure 4A]. In addition, the synthesis technique enables the surface of Ti3C2Tx to form abundant
Figure 4. (A) Synthesis of Oxid-Ti3C2Tx/UIO-66-NH2 composites; (B) Zeta potential of Ti3C2Tx; (C) SEM image of Ti3C2Tx; (D) SEM images of Oxid-Ti3C2Tx/UIO-66-NH2; (E) TEM images of Ti3C2Tx; (F)TEM images of Oxid-Ti3C2Tx/UIO-66-NH2; (G and H) EDXS (G), HRTEM (H) images of Oxid-Ti3C2Tx/UIO-66-NH2; (I) XRD patterns of Ti3AlC2, Ti3C2Tx, and Oxid-Ti3C2Tx/UIO-66-NH2 composites (J) XPS spectra of Ti3C2Tx, and Oxid-Ti3C2Tx/UIO-66-NH2 composites Ce-MOF@PA; (K) Raman spectra of Ti3C2Tx treated by DBD with different times; (L) Before enrichment and (M) after enrichment by Oxid-Ti3C2Tx/UIO-66-NH2. (A-M) are reprinted with permission from Ref.[101], Copyright © 2023 by Elsevier Ltd. Permission is not required for this non‑commercial use. SEM: Scanning electron microscope; TEM: transmission electron microscope; EDXS: energy-dispersive X-ray spectroscopy; HRTEM: high-resolution transmission electron microscopy; XRD: X-ray diffraction; XPS: X-ray photoelectron spectroscopy; MOF: metal–organic framework; PA: phytic acid; DBD: dielectric barrier discharge.
Du et al. proposed a novel strategy for phosphopeptide enrichment based on the complementary effects of (PEI) functionalized magnetic nanospheres and bimetal ions[102]. The synthesis process is shown in Figure 5A.
Figure 5. (A) Synthetic procedure for Fe3O4@PDA@MIL(Ti)-PEI-Nb; (B) FT-IR spectra of (i) Fe3O4, (ii) Fe3O4@PDA, (iii) Fe3O4@PDA@MIL(Ti)-PEI, (iv) Fe3O4@PDA@MIL(Ti)-PEI-Nb; (C) XPS spectrum of Fe3O4@PDA@MIL(Ti)-PEI-Nb; (D) SEM image of Fe3O4@PDA@MIL(Ti)-PEI-Nb; (E) TEM image of Fe3O4@PDA@MIL(Ti)-PEI-Nb; (F) EDX spectrum of Fe3O4@PDA@MIL(Ti)PEI-Nb. The inset in (F) is the primary elements content table of EDX; Mass spectra of human saliva: (G) before and (H) after enrichment with Fe3O4@PDA@MIL(Ti)-PEI-Nb. (A-H) are reprinted with permission from Ref.[102], Copyright © 2021 by Elsevier Ltd. FT-IR: Fourier transform infrared spectroscopy; XPS: X-ray diffraction; SEM: scanning electron microscope; TEM: transmission electron microscope; EDX: energy-dispersive X-ray spectroscopy.
Characterization results like SEM, TEM, XRD and FT-IR [Figure 5B-F] verified that the material is successfully synthesized, and it is then used for the efficient enrichment of phosphopeptides. The material showed extremely high detection sensitivity (0.1 fmol) and excellent selectivity, and can effectively capture phosphopeptides even at a molar ratio of 1:5,000 and successfully extract 34 phosphopeptides from saliva samples [Figure 5G and H]. The novel point of this research lies in its research method, through the synergistic effect of complementary bimetal ions (Ti4+ and Nb5+) and PEI, efficient enrichment of monophosphorylated peptides and polyphosphorylated peptides is significantly achieved. The material achieves comprehensive and efficient enrichment for the following reasons. Firstly, Nb5+ has a greater predilection for multiphosphopeptides, while Ti+ has a high affinity for monophosphopeptides. The material can concurrently capture both kinds of phosphopeptides by integrating both metal ions into the same framework, guaranteeing wide coverage across various phosphorylation states. Secondly, the amino groups on the branching PEI become extensively protonated under the acidic enrichment conditions, creating a thick positively charged layer. Strong electrostatic attraction toward negatively charged phosphopeptides is made possible by this high cationic density, which significantly increases enrichment efficiency. Thirdly, the material integrates the metal ion affinity chromatography (IMAC) mechanism - through coordination between Ti4+/Nb5+ and phosphate groups - with electrostatic attraction from the cationic field generated by PEI. This dualcapture mechanism collectively improves sensitivity, selectivity, and loading capacity.
Co-enrichment of glycopeptides and phosphorylated peptides
MOFs have shown extensive application potential in proteomics and peptidomics research with their unique pore structure and rich surface chemical properties[103]. Protein phosphorylation and glycosylation are the two most common and critical types of PTMs in eukaryotes[104]. By regulating a variety of cellular activities such as signal transduction[105], immune response[106], and cell proliferation[107], they participate in the precision regulatory network of living organisms. Notably, the abnormal expression of these two modified types is closely related to the occurrence and development of multiple diseases. Particularly, the interaction between them can regulate the hyperphosphorylation of tau protein, which is considered to be one of the core pathological features of Alzheimer’s disease (AD)[108]. However, achieving simultaneous characterization of these two types of PTMs in complex biological sample matrix remains a very challenging topic in current proteomics research. In the current research, multifunctional MOFs integrating hydrophilic ligands and phosphate-affinity metal centers are designed using HILIC and metal oxide affinity chromatography (MOAC) as core enrichment techniques. Such MOFs’ structure enables the simultaneous enrichment of glycopeptides and phosphopeptides by combining the synergistic effects of MOAC-mediated metal coordination and HILIC-based hydrogen bonding.
Wu et al. developed a multifunctional MOF composite (mMIL-125@Au@L-Cys) for the efficient enrichment and identification of N-linked glycopeptides and phosphopeptides in human lens tissues[109]. The synthesis reaction is as follows [Figure 6A]. The material integrated the hydrophilic properties of L-Cys, the strong phosphopeptide-binding affinity of Ti-O clusters, the large specific surface area characteristic of MOFs, and the superparamagnetic behavior of Fe3O4 NPs. SEM, TEM characterization confirmed the successful stepwise synthesis [Figure 6B], including the formation of Fe3O4@PDA core-shell, the grafting of MIL-125 (evidenced by surface roughness), the deposition of uniform Au NPs measuring less than 10 nm, and the final L-Cys functionalization via Au–S bonds. FT-IR further confirmed the successful synthesis of this material [Figure 6C]. XRD analysis [Figure 6D] was performed to characterize the crystalline structures of both mMIL-125 and Au NPs. TEM [Figure 6E] characterization also confirmed the successful stepwise synthesis. These results confirmed the coexistence of mMIL-125 and Au NPs in the composite material. The developed material demonstrated good enrichment performance for both glycopeptides and phosphopeptides from standard proteins, achieving limit of detection of 0.1 fmol/mL and maintaining stability over 5 reuse cycles. The material successfully identified numerous N-linked glycopeptides and phosphopeptides in human lens proteins [Figure 6F and G], highlighting its potential for glycoproteomic and phosphoproteomic research. Furthermore, this study established a novel method for constructing functional MOF materials through post-modification strategies, providing a valuable framework for advancing proteomic studies.
Figure 6. (A) The synthetic strategy of mMIL-125@Au@L-Cys and (B) TEM images of mMIL-125@Au@L-Cys; (C) FT-IR spectra of Fe3O4@PDA, mMIL-125 and mMIL-125@Au@L-Cys; (D) XRD of mMIL-125@Au@L-Cys; (E) SEM images of mMIL-125@Au@L-Cys: magnified for 30,000 times; (F and G) MALDI-TOF MS for the phosphopeptides from a mixture of β-casein and BSA tryptic digests with a mass ratio of 1:100: (a) before enrichment, (b) after enrichment. for the glycopeptides from a mixture of HRP and BSA tryptic digests with a mass ratio of 1:100: (c) before enrichment, (d) after enrichment; Peaks of glycopeptides and phosphopeptides are marked with red stars and red triangles indicate the losses of phosphoric acid (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article); (H) The Synthetic route for Fe3O4@PDA@UiO-66-NH2; (I) Workflow of glycopeptide or phosphopeptide enrichment from biological samples using Fe3O4@PDA@UiO-66-NH2; (J) SEM images of Fe3O4@PDA@UiO-66-NH2; (K) XRD patterns of Fe3O4@PDA@UiO-66-NH2. MALDI-TOF MS for the glycopeptide enrichment from 250 fmol/mL; HRP tryptic digest: (L) after treatment with the first-time Fe3O4@PDA@UiO-66-NH2; (M) for the phosphopeptide enrichment from 200 fmol/mL β-casein tryptic digest: after treatment with the first-time Fe3O4@PDA@UiO-66-NH2. (A-G) are reprinted with permission from Ref.[109], Copyright © 2019 by Elsevier B.V. (H-M) are reprinted with permission from Ref.[110], Copyright © 2017 by Springer Nature. TEM: Transmission electron microscope; FT-IR: Fourier transform infrared spectroscopy; XRD: X-ray diffraction; SEM: scanning electron microscope; MALDI-TOF MS: matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; BSA: bovine serum albumin; HRP: horseradish peroxidase.
Xie and Deng needed a dual-functional hydrophilic magnetic amino-modified MOF for the selective enrichment of glycopeptides and phosphopeptides[110]. The fabrication process began with the solvothermal synthesis of magnetic Fe3O4 cores, followed by the self-polymerization of dopamine to form a polydopamine (PDA) coating on their surfaces. The hydroxyl and amino groups of PDA facilitated the immobilization of Zr3+ ions, which subsequently reacted with amino ligands via a one-pot MOF synthesis, yielding Fe3O4@PDA@UiO-66-NH2 [Figure 6H and I]. The resultant material was characterized using SEM, XRD [Figure 6J and K]. SEM images revealed a thin polymer shell on the spherical Fe3O4 microspheres. The UiO-66-NH2 modification imparted MOFs with crystalline surfaces, contracting with the smoothness of Fe3O4@PDA. XRD displayed the characteristic peaks, confirming the successful synthesis. As shown in Figure 6L and M, horseradish peroxidase (HRP, a typical glycoprotein) and β-casein (a typical phosphoprotein) were enriched using Fe3O4@PDA@UiO-66-NH2 material, demonstrating the high efficiency and selectivity of this material in enriching glycopeptides and phosphopeptides.
This study successfully designed and synthesized Fe3O4@PDA@UiO-66-NH2, a material that effectively enriches both glycopeptides and phosphorylated peptides. The idea of a “dual-application” material that combined HILIC and immobilized IMAC technologies to expedite experimental procedures is a significant innovation. The material demonstrated high sensitivity and selectivity in tests with standard proteins and human serum, achieving detection limits as low as 0.2 fmol/mL for glycopeptides and 0.02 fmol/mL for phosphorylated peptides, along with maximum binding capacities of 4 and 0.8 mg/g, respectively. A successful application in complex biological samples, including human serum, revealed 307 N-glycosylated peptides and 33 phosphorylated peptides, demonstrating its good potential in glycoproteomics and phosphoproteomics research. Experimental validation also verified its stability and reproducibility.
Separation of protein
Protein purification serves as a crucial foundational technique for proteomics research in the life sciences[111,112]. Therefore, the preparation of high-performance protein separation materials holds significant importance. Taking into account the substantial size and intricate structural nature of proteins, a digestion approach exhibiting site-specific selectivity is highly ideal.
Qian et al. initially synthesized carboxyl-functionalized carbon nanoparticles (CNs) as the substrate[113]. Subsequently, UIO-66 crystals were grown in situ on these substrates to construct CN@UIO-66 composite carriers. To minimize non-specific protein adsorption, zwitterionic monomers were incorporated during the molecular imprinting process. Using cytochrome c as the template protein, the team successfully prepared CN@UIO-66@MIPs via surface imprinting technology. The preparation process is illustrated in Figure 7A. The effective synthesis of the composite material was confirmed by its characterization using SEM and TEM [Figure 7B and C]. Figure 7D and E presents the effects of two key parameters - protein-immobilizing carrier type and the loading of zwitterionic monomer DMAPS [3-dimethyl-(methacryloyloxyethyl) ammonium propane sulfonate] - on both the recognition ability and selectivity of molecularly imprinted polymers (MIPs). Collectively, these results confirm that the CN@UIO-66 composite carrier offers distinct advantages when constructing high-performance protein-imprinted materials.
Figure 7. (A) Illustration of the synthesis of CN@UIO-66@MIPs; (B) SEM image of CN@UIO-66@MIPs; (C) TEM image of CN@UIO-66@MIPs; Influence of the protein immobilization carrier (D) and DMAPS (E) content (the white and black numbers representing IF and β values, respectively) on the recognition and selectivity of the MIPs; (F) Fabrication of magnetic carbonized PDA@F127/ZIF-67 hollow nanocages; (G) High resolution XRD spectrum of carbonized PDA@F127/ZIF-67 NPs; (H) SEM image of carbonized PDA@F127/ZIF-67 NPs; (I) TEM image of carbonized PDA@F127/ZIF-67 NPs; (J) Influence of pH on the adsorption properties of the carbonized PDA@F127/ZIF-67 nanocages; (K) Spiked fetal calf serum analyzed by SDS-PAGE. Lane 1, protein molecular weight marker; lane 2, spiked fetal calf serum diluted 40-fold; lane 3, the supernatant after the enrichment by carbonized PDA@F127/ZIF; lane 4, the elute; lane 5, 0.2 mg·mL-1 BHB standard solution; MALDI-TOF MS analyses for (L) 40-fold dilution of spiked fetal calf serum and (M) the eluate. (A-E) are reprinted with permission from Ref.[113], Copyright © 2021 by American Chemical Society. (F-M) are reprinted with permission from Ref.[114], Copyright © 2020 by American Chemical Society. SEM: Scanning electron microscope; TEM: transmission electron microscope; DMAPS: 3-dimethyl-(methacryloyloxyethyl) ammonium propane sulfonate; MIPs: molecularly imprinted polymers; XRD: X-ray diffraction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; BHB: bovine hemoglobin; MALDI-TOF MS: matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
This study successfully prepared raspberry-like cytochrome C surface-imprinted NPs based on CN@UIO-66 composites, demonstrating excellent adsorption capacity (815 mg∙g-1), rapid equilibrium time (< 40 min), and remarkable recognition specificity (IF = 6.1). The innovative strategy of combining MOF composites with zwitterionic monomers can effectively overcome mass transfer limitations and non-specific binding problems in traditional methods, thus enabling efficient enrichment and specific recognition of targets in complex protein mixtures and biological samples.
Tan et al. prepared a novel MOF-derived polymer-mediated magnetic hollow carbon nanocage for the selective enrichment of bovine hemoglobin (BHB) proteins[114]. The preparation process is illustrated in Figure 7F. The as-prepared nanocages were systematically characterized using XRD, SEM, TEM, and vibrating sample magnetometry (VSM) [Figure 7G-I]. All characterization results collectively confirmed the successful synthesis of the nanocages. Figure 7J is mainly used to analyze the surface charge properties of nanomaterials and their influence on the adsorption behavior of the target protein (BHB) under different pH conditions. Figure 7K-M shows the capture and enrichment of BHB protein by carbonized PDA@F127/ZIF-67 nanocages in real biological samples (e.g., fetal bovine serum and bovine serum). This confirms the feasibility and efficiency of this material for enriching target proteins in complex biological samples. This study validated that magnetic hollow carbon nanocages exhibited excellent adsorption ability on BHB in complex biological samples. The novelty of this study is the development of a stress-induced oriented contraction method to prepare magnetic hollow carbon nanocages with graded pore structures, which effectively overcoming the limitations of the inefficient adsorption ability and cumbersome separation process of traditional MOF-derived materials. This stratified hollow porous structure significantly increases the specific surface area, reduces mass transfer resistance, and reinforce the high affinity adsorption capacity of the target protein BHB. Experimental results revealed that the adsorption capacity of this material to BHB is up to 834.3 mg·g-1, which is significantly more than other methods reported in existing literature, and provides broad application prospects for the separation and purification of complex biological sample.
APPLICATION OF COFS IN BIOSEPARATION
COFs are highly crystalline organic polymers with large surface areas, tunable pore sizes and geometries, versatile functionalization, and relatively high thermal and chemical stability[115]. Due to their unique structures and properties, they have demonstrated broad application prospects in areas such as glycopeptide separation[116], phosphopeptide separation[117,118], protein separation[119,120], adsorption[121], and small molecule separation[122-124].
Separation of peptides
Separation of glycopeptides
In recent years, COFs have been widely utilized for the efficient separation and enrichment of glycopeptides, making them ideal candidates for glycoproteomic analysis in complex biological samples. These materials achieve strong hydrophilicity and high affinity for glycopeptides through the incorporation of hydrophilic functional groups, such as PEI, boronic acid, and glutathione (GSH)[125-128]. Moreover, by integrating with NPs - such as gold or silver - the number of available binding sites is significantly increased, thereby enhancing interactions with glycopeptides and improving capture efficiency[125,126,129].
In 2022, Ji et al. developed a hierarchical flower-like hollow composite (HFH-COFs@Au@GSH) by anchoring Au NPs via sodium citrate reduction and functionalizing with GSH through Ag–S bonds [Figure 8A][127]. TEM confirmed the preservation of the hollow morphology (450-550 nm) after Au NP and GSH loading, with a specific surface area retention of 634.7 m2/g (vs. 2,324.8 m2/g for pristine HFH-COFs). The flower-like hollow architecture of the material, endowed with hierarchical porosity and internal cavities, not only confers structural stability and abundant binding sites but also facilitates glycopeptide accessibility and shortens diffusion pathways, thereby enabling rapid adsorption [Figure 8B]. After enrichment with HFH-COFs@Au@GSH, 49.59% of the sequences were identified as the NXT sequence, which is the primary site for N-glycosylation in eukaryotes. Additionally, this material captured 8.94% of the NXC sequence. This indicates that the material possesses the ability to enrich atypical N-glycosylation sites and exhibits high coverage [Figure 8C]. The -SH groups in GSH directly interact with sialic acid residues on N-glycopeptides, enabling highly selective enrichment with a detection limit of 0.1 fmol/μL - superior to most reported materials. The WebLogo shows that within the broad range of “-7 to +7”, the occurrence frequency of hydrophilic amino acids [such as serine (S), threonine (T), etc.] is significantly higher. This reflects the enrichment mechanism of the material, where the hydrophilic GSH modified on the material surface binds to N-glycopeptides through “HILIC” [Figure 8D]. GO functional annotation of glycoproteins was performed from the dimensions of cellular component, biological process, and molecular function, respectively, which clarified the biological functions of N-glycoproteins [Figure 8E-G]. This selectivity was further validated by the successful identification of 308 N-glycopeptides in human serum, demonstrating the material’s practical utility in glycoproteomics. The synergy between the hierarchical structure (for high capacity) and GSH’s specificity (for molecular recognition) establishes this composite as a robust platform for sensitive glycopeptide analysis in complex biological matrices.
Figure 8. (A) Preparation process of HFH-COFs@Au@GSH with TEM image; (B) Workflow of N-glycopeptide enrichment using the HFH-COFs@Au@GSH; (C) N-Glycosylation sites identified from human serum; (D) Web-Logos of N-glycosylation sites identified from human serum; GO analysis by DAVID for the identified glycoproteins from human serum, including the cellular component (E), biological process (F), and molecular function (G); (H) Synthetic schematics of TbBD@PEI@Au@4-MPBA composites and Enrichment procedure of glycopeptides by TbBD@PEI@Au@4-MPBA; (I and J) SEM (I) and TEM (J) images of the TbBD@PEI@Au@4-MPBA. (A-G) are reprinted with permission from Ref.[127], Copyright © 2022 by Royal Society of Chemistry. (H-J) are reproduced with permission from Ref.[125], Copyright © 2022 by Elsevier. GSH: Glutathione; TEM transmission electron microscopy; GO: Gene Ontology; DAVID: database for annotation, visualization, and integrated discovery; TbBD: 1,1,4,4-tetraphenyl-1,3-butadiene; PEI: polyethyleneimine; MPBA: mercaptophenylboronic acid; SEM: scanning electron microscope.
Xie et al. constructed a boronic acid-functionalized COF composite (TbBD@PEI@Au@4-MPBA) for highly selective glycopeptide enrichment[125], where the COF substrate provides a high surface area and stable pore structure, PEI enhances hydrophilicity and serves as a stabilizer for in-situ growth of Au NPs, and 4-MPBA, anchored via Au–S bonds, introduces abundant boronic acid groups that specifically bind glycopeptides through reversible boronate ester bonds under alkaline conditions, with release achieved under acidic elution [Figure 8H]. Structural characterization (SEM/TEM) revealed spherical aggregates (~25 nm) embedded with Au NPs (~15 nm) [Figure 8I and J], whose regular and tunable pore architecture enables selective sieving of target glycopeptides. This design enabled ultra-sensitive enrichment (detection limit: 5 amol/μL) and high selectivity (1:1,000, HRP/BSA), with minimal nonspecific adsorption due to PEI’s hydrophilic shielding. The composite successfully identified 56 endogenous glycopeptides in saliva and 513 disease-related glycopeptides in laryngeal cancer serum, showing excellent reusability (10 cycles) and stability (2 months at room temperature).
Magnetic COF materials enable efficient glycopeptide enrichment with rapid separation/recovery capabilities for high-throughput operations. In 2020, Wu et al. developed a magnetic COF material (mCTpBD) designed to enhance the selective enrichment of glycopeptides through multiple synergistic mechanisms, including hydrophilic interactions and size-exclusion effects[116]. The material was synthesized by interfacial deposition, with an average diameter of 398 nm [Figure 9A]. The TEM images of mCTpBD show that compared with Fe3O4−NH2, mCTpBD still maintains a spherical morphology, which intuitively verifies the successful construction of the “magnetic core-hydrophilic COF shell” core-shell structure [Figure 9B]. The detection results of HRP digests, obtained by comparing the “pre-enrichment” samples with those “after enrichment using mCTpBD”, showed that after enrichment with mCTpBD, the number and intensity of glycopeptide characteristic peaks in the spectrum were significantly increased. The core reason for this lies in the inherent hydrophilicity of mCTpBD [Figure 9C and D]. The introduction of CTp endowed the material with intrinsic hydrophilicity, facilitating efficient binding to glycopeptides in complex biological matrices. The microporous structure further improved selectivity by excluding macromolecular interferences, while the imine bonds (C=N) and aromatic rings (C=C) in the COF layer promoted π–π stacking interactions with glycopeptides. In a 1:50 mixture of HRP and BSA digests, mCTpBD successfully enriched 15 glycopeptides, with no significant performance loss observed over five reuse cycles. The material exhibited a high enrichment sensitivity of 0.5 fmol/μL for standard glycopeptides, outperforming previously reported COF-based materials. When applied to real-world samples, mCTpBD enabled the identification of 28, 32, and 49 endogenous glycopeptides from saliva samples of three healthy individuals, and 27, 39, and 40 glycopeptides from patients with inflammatory bowel disease, using nano-LC-MS/MS analysis. These results highlight its practical applicability in complex biological systems. Additionally, the material retained strong magnetic responsiveness (saturation magnetization: 50.49 emu/g), enabling rapid separation under an external magnetic field. Then in 2022, Su’s team[128] developed a magnetic COF composite (Fe3O4@TpBD@Au@GSH) for efficient and selective glycopeptide enrichment, combining rapid separation capability with high adsorption capacity. The material was constructed by coating 400 nm Fe3O4 spheres with TpBD to form a 150 nm smooth layer, followed by in-situ modification with Au NPs and GSH via Au–S bonds, resulting in a final particle size of ~900 nm with a coarse surface morphology confirmed by SEM [Figure 9E and F]. The synergistic effect of TpBD’s hydroxyl/amino groups and GSH’s carboxyl/amino groups created dual hydrophilic binding sites, achieving a high adsorption capacity of 160 mg/g and excellent selectivity with resistance to protein interference at a ratio of 1:2,000 [Figure 9G and H]. This structural design enabled ultra-sensitive glycopeptide enrichment and highly specific capture, as demonstrated by the detection of 21 HRP glycopeptides even after 3 months of storage at room temperature, along with stable performance over six reuse cycles, highlighting its practical applicability in complex biological samples.
Figure 9. (A) Graphical synthetic route of CTp and mCTpBD, respectively, and enrichment procedure of glycopeptides by mCTpBD; (B)TEM images of mCTpBD; MALDI-TOF MS of HRP tryptic digest (100 fmol/μL) (C) before the enrichment, and (D) after the enrichment by mCTpBD. The peaks of glycopeptides are marked with a red asterisk (*); (E) The synthetic route of Fe3O4@TpBD@Au@GSH; (F) SEM of Fe3O4@TpBD@Au@GSH; MALDI-TOF MS of the mixture of HRP tryptic digests and BSA proteins at various molar ratios after enrichment by Fe3O4@TpBD@Au@GSH (G) 1:1,000, (H) 1:2,000. (A-D) are reprinted with permission from Ref.[116], Copyright © 2020 by American Chemical Society. (E-H) are reproduced with permission from Ref.[128], Copyright © 2022 by Elsevier. CTp: Carboxyl-modified 1,3,5-triformylphloroglucinol; mCTpBD: magnetic carboxyl-modified 1,3,5-triformylphloroglucinol-benzidine covalent organic framework; TEM: transmission electron microscopy; MALDI-TOF MS: matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; HRP: horseradish peroxidase; Tp: 2,4,6-trihydroxybenzene-1,3,5-tricarbaldehyde; BD: benzidine; GSH: glutathione; SEM: scanning electron microscope; BSA: bovine serum albumin.
COF and its composites have become cutting-edge tools in the field of glycopeptide separation and enrichment due to their highly adjustable structure and excellent hydrophilicity. They exhibit high sensitivity and selectivity in complex biological samples, advancing glycoproteomics and disease marker research. The synthesis steps of some materials are complex, and there is still room for improvement in the separation of very low-abundance glycopeptides in practical applications.
Separation of phosphorylated peptides
Protein phosphorylation is a key PTM involved in various biological processes, and its dysregulation is closely linked to diseases such as cancer and diabetes[130,131]. Due to their low abundance and interference from complex biological matrices, efficient enrichment is essential for sensitive detection of phosphorylated peptides[132]. COFs, with their high surface area, tunable pore structures, and versatile functionalization, have shown great promise in glycopeptide enrichment. These features make COFs a compelling platform for developing advanced materials for selective phosphopeptide capture, offering significant potential in proteomics and biomedical research.
By introducing functional groups such as metal ions such as Ti4+ or guanidine groups, COF materials can achieve high affinity enrichment of phosphorylated peptides, which, combined with magnetic NPs, facilitate rapid separation and recovery, making them suitable for high-throughput processing of complex biological samples. Wang’s team[133] designed a titanium-functionalized 2D-COF (TpPa-2-Ti4+) for highly selective phosphopeptide enrichment [Figure 10A]. SEM/TEM revealed elongated sheet-like nanostructures offering abundant surface binding sites, and the mesoporous architecture (2.8 nm) effectively excluded large interferences like serum albumin while allowing selective access of small phosphopeptides. The Ti4+–phosphate coordination served as the primary driving force for enrichment, assisted by hydrogen bonding and electrostatic interactions between framework-bound polar groups and phosphopeptides. The chelation between metal cations and phosphate groups, along with the hydrophilic adsorption of PEG groups, inhibits nonspecific hydrophobic adsorption, synergistically enabling efficient and selective enrichment of phosphorylated peptides. The limit of detection is as low as 0.02 fmol/μL. The phosphorylated peptide is still specifically enriched with a 1:100 molar ratio of α-casein to BSA with a clean background signal. It identified 18 and 17 phosphopeptides from α-casein digests with and without BSA (1:50), respectively, outperforming commercial TiO2 beads, and successfully enriched 12 from skim milk and 7,432 from HeLa cells, demonstrating high sensitivity, selectivity, and practical applicability in complex biological samples.
Figure 10. (A) Schematic illustration of synthesis of TpPa-2-Ti4+ through condensation and coordination with chemical structure of TpPa-2 and chemical structure of TpPa-2-Ti4+; (B) Representation of the strategy for preparing Zr4+-immobilized magnetic COFs through sequential post-synthetic modifications; (C) Schematic representation of preparation of TpTGCl CONs, and enrichment procedure of phosphopeptides with TpTGCl CONs; (D) Powder XRD patterns of simulated and as-synthesized TpTGCl CONs; (E) TEM image of TpTGCl CONs; (F) AFM image and height profile of TpTGCl CONs. MALDI-TOF MS of non-fat milk tryptic digest; Direct analysis (G), after enrichment by TpTGCl CONs in buffer A (H). MALDI-TOF MS of human saliva (5 μL); Direct analysis (I), after enrichment by TpTGCl CONs in buffer A (J) (“s” in blue indicates mono-phosphopeptide, “m” in red indicates multi-phosphopeptide. For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article); (K) Distribution proportions of mono- and multi-phosphopeptides identified from rat liver protein digest by TpTGCl CONs in buffer A and buffer B, respectively. And distribution proportions of the integrated phosphorylation sites identified from rat liver protein digest by TpTGCl CONs in buffer A and buffer B; GO analysis by DAVID for the identified phosphoproteins from rat liver protein digest, including biological process (L), molecular function (M). (A) is reprinted with permission from Ref.[133], Copyright © 2017 by Elsevier. (B) is reproduced with permission from Ref.[134], Copyright © 2021 by American Chemical Society. (C-M) are reproduced with permission from Ref.[135], Copyright © 2021 by Elsevier. Tp: 1,3,5-Triformylphloroglucinol; Pa-2: 2,5-dimethyl-1,4-benzenediamine; COFs: covalent organic frameworks; TGCl: triaminoguanidinium chloride; CONs: covalent organic nanosheets; XRD: X-ray diffraction; TEM: transmission electron microscopy; AFM: atomic force microscopy; MALDI-TOF MS: matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; GO: Gene Ontology; DAVID: database for annotation, visualization, and integrated discovery.
Gao et al. developed a magnetic three-layer composite material with a COF shell for highly selective phosphopeptide enrichment[134]. The structure consists of magnetic colloidal nanocrystalline clusters (MCNCs) as the core, a COF layer synthesized from TfPb and DHBD as the middle shell, and Zr4+ ions anchored on the surface via coordination with phosphate groups introduced through succinic anhydride (SA) and PA modification [Figure 10B]. This “magnetic nucleus–functionalized COF shell–Zr4+ active site” design enables specific phosphopeptide capture via Zr4+–phosphate coordination under neutral conditions, with elution achieved under acidic conditions [2% trifluoroacetic acid (TFA)], while the mesoporous structure (2.7-3.3 nm) excludes large proteins. Therefore, it is suitable for the diffusion of small phosphorylated peptides while repelling large proteins (such as BSA) to achieve a size exclusion effect. The magnetic core provides rapid separation within 1 min under an external field (saturation magnetization: 42.4 emu/g), facilitating efficient handling in complex biological samples. With a positively charged surface minimizing nonspecific adsorption, the material achieved a detection capacity of 46.48 μg/mg and successfully enriched 3 phosphopeptides from 0.25 μg/mL β-casein digest at a BSA/β-casein molar ratio of 200:1. It also identified 14 phosphopeptides from skim milk and detected endogenous phosphorylated peptides from diluted human serum. In 2021, He et al. synthesized two-dimensional guanidine-rich covalent organic nanosheets (TpTGCI CONs) via a simple solvothermal Schiff-base reaction between 1,3,5-triformylphloroglucinol (Tp) and triaminoguanidine hydrochloride (TGCl), yielding layered nanosheets with abundant guanidine groups that enable pH-tunable phosphopeptide recognition [Figure 10C][135]. With a thickness of ~6 nm (3-6 layers), a diameter of ~2 μm, and a specific surface area of 251 m2/g, the material offers numerous accessible active sites for efficient binding. Structural characterization confirmed the successful formation of COF architecture: PXRD showed characteristic peaks at ~9.7° and ~27.3°, consistent with hexagonal layering and π–π stacking [Figure 10D]; TEM and SEM revealed thin, folded sheet-like morphology; atomic force microscopy (AFM) verified the nanosheet thickness [Figure 10E and F]. The interlayer spacing allows selective entry of small phosphopeptides while excluding larger proteins, significantly enhancing selectivity. Benefiting from the strong polar interactions between guanidine groups and phosphate moieties, the material achieved an ultralow detection limit of 0.05 fmol/μL for global phosphopeptides, demonstrating excellent potential for sensitive biomarker screening in complex biofluids such as serum and saliva. For the enrichment of phosphopeptides from the tryptic digest of non-fat milk, 8 mono-phosphopeptide peaks and 18 multi-phosphopeptide peaks were clearly identified [Figure 10G and H]. For the enrichment of endogenous phosphopeptides in human saliva, no phosphopeptide peaks were observed in the spectrum during direct detection. However, after enrichment with TpTCI CONs, 9 mono-phosphopeptide peaks and 12 multi-phosphopeptide peaks were identified [Figure 10I and J]. Through Gene Ontology (GO) analysis, the biological significance of phosphorylated proteins enriched from rat liver proteins by TpTGCI CONs was systematically illustrated from three dimensions [Figure 10K-M].
Co-enrichment of glycopeptides and phosphorylated peptides
Bifunctional COF materials introduce specific functional groups, such as MUBA, iron ions, amino groups, etc., and use hydrogen bonds, metal ion coordination and hydrophilic interactions to achieve synergistic recognition and enrichment of phosphorylated peptides and glycopeptides[136,137].
In recent years, there have been several notable advancements in the application COFs for co-enrichment, showcasing their potential in various analytical and separation tasks. For instance, in 2021, Luo’s team[138] developed a core-shell magnetic COF material, MCNC@Polymer@COF-MUBA, for efficient co-enrichment of glycopeptides and phosphopeptides [Figure 11A]. The hydrophilic COF surface facilitates hydrophilic interaction with glycopeptides, while the urea group in MUBA forms multiple hydrogen bonds with phosphate groups of phosphopeptides, reducing non-specific adsorption [Figure 11B]. The material allows either simultaneous or selective enrichment by tuning conditions. Under high interference (IgG:α-casein:BSA = 1:1:1,000), 21 glycopeptides and 18 phosphopeptides were identified [Figure 11C and D]. From rat liver digest, 1,717 unique glycopeptides (898 glycoproteins) and 1,997 phosphopeptides (1,100 phosphoproteins) were captured, including 229 dual-modified proteins, demonstrating high efficiency and coverage [Figure 11E]. Exosomes isolated from hepatocellular carcinoma patient plasma (confirmed by cup-shaped morphology in TEM and markers CD9/CD63/CD81 in Western blot, Figure 11F and G) yielded 293 glycopeptides (180 glycoproteins) and 116 phosphopeptides (76 phosphoproteins) after enrichment, highlighting its selectivity and applicability in complex biological samples [Figure 11H].
Figure 11. (A) Schematic representation of the synthesis of MCNC@polymer@COF-MUBA nanospheres; (B) Schematic diagram of the binding modes and controllable selective enrichment of the nanospheres for phosphopeptides and glycopeptides; (C) MALDI-TOF MS of peptide mixtures of tryptic digests of IgG, α-casein, and BSA with a molar ratio of 1:1:500 direct analysis; (D) MALDI-TOF MS of peptide mixtures of tryptic digests of IgG, α-casein, and BSA with a molar ratio of 1:1:1,000 after enrichment with the nanospheres. Glycopeptides are marked with red arrows and phosphopeptides are marked with blue arrows (For interpretation of the references to color in this Figure legend, the reader is referred to the Web version of this article); (E) The numbers of glycopeptides (glycoproteins) and phosphopeptides (phosphoproteins) identified using the nanospheres from mouse liver digests; (F) TEM negative staining analysis of the obtained exosomes; (G) Western blot analysis of the proteins collected from exosomes and three exosome markers (CD-9, CD-63, and CD81) were used; (H) Numbers of glycopeptides (glycoproteins) and phosphopeptides (phosphoproteins) in the exosome lysate identified using the material. (A-H) are reprinted with permission from Ref.[138], Copyright © 2021 by Elsevier. MCNC: Magnetic colloidal nanocrystalline cluster; COF: covalent organic framework; MUBA: 4-(3-(2-(methacryloyloxy)ethyl)-ureido)benzoic acid; MALDI-TOF MS: matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; IgG: immunoglobulin G; BSA: bovine serum albumin; TEM: transmission electron microscope.
In 2022, Xiong et al. developed Fe3O4@Thio-COF@Au@GSH, a magnetic zwitterionic COF designed for the efficient enrichment of glycopeptides and phosphopeptides [Figure 12A-C][139]. This material integrates multiple functional components. GSH provided strong hydrogen bonding with glycan chains and electrostatic interactions with phosphate groups in exosomal membranes, ensuring stable binding [Figure 12D and E]. The material demonstrated excellent sensitivity, detecting glycopeptides at 0.2 fmol and phosphopeptides at 0.4 fmol, and maintained high selectivity even in the presence of a 1,000-fold excess of BSA. It successfully identified 419 glycopeptides and 316 phosphopeptides from urinary exosomes, including 42 proteins with dual modifications involved in key cellular processes. Supported by theoretical calculations and protein interaction network analysis, this design integrates exosome capture with targeted peptide enrichment, offering a powerful platform for exosome proteomics and PTM analysis, with excellent reusability over five cycles. In addition to electrostatic action, the electron-rich P atom in the phosphate group forms intermolecular hydrogen bonds (marked with a blue dotted line), further enhancing binding stability. The interaction subnets predicted by STRING 11.0 show that they may play a synergistic role in translation, protein phosphorylation, glycosylation, and localization, indicating that glycosylation and phosphorylation modifications in exosomes may affect protein function and recognition, providing clues to understanding the role of exosomes in cellular activity [Figure 12F].
Figure 12. (A) Synthetic route of Fe3O4@Thio-COF@Au@GSH; (B) Workflow for the enrichment of glycopeptides and phosphopeptides in standard samples by Fe3O4@Thio-COF@Au@GSH individually; (C) Workflow of the consecutive enrichment of exosomes and exosomal glycopeptides/phosphopeptides from urine samples using Fe3O4@Thio-COF@Au@GSH; (D) Calculated electron density mapped with the electrostatic potential of GSH/phosphate head group; (E) Possible interaction model between GSH and the phosphate head group. Hydrogen bonds are represented by blue dashed lines; (F) Protein–protein interaction network of the identified 42 proteins with the co-existence of glycosylation and phosphorylation; (G) Preparation diagram of ferrocene COF; (H and I) TEM (H) and SEM (I) images of FE-1; (J) Mass spectrum of eluent obtained by enriching glycopeptides in IgG enzymatic hydrolysate with FE-1 COF material; (K) Mass spectrum of eluent obtained by enriching phosphopeptides in α-casein enzymatic hydrolysate with FE-1 COF material. (A-F) are reprinted with permission from Ref[139], Copyright © 2022 by Royal Society of Chemistry. (G-K) are reproduced with permission from Ref.[140], Copyright © 2024 by Multidisciplinary Digital Publishing Institute. Thio-COF: Thioether-functionalized covalent organic framework; GSH: glutathione; TEM: transmission electron microscopy; SEM: scanning electron microscope; IgG: immunoglobulin G.
The integration of HILIC and IMAC dual mechanisms allows for synergistic recognition and efficient co-enrichment of glycopeptides and phosphorylated peptides. In 2024, Wu’s team[140] developed a ferrocene-based FE-1 COF via imine bonding, designed for dual recognition and selective enrichment of glycopeptides and phosphorylated peptides [Figure 12G]. Material characterizations (including XPS, FT-IR, Ms, TEM, and SEM) confirm that FE-1 COF has a well-defined structure, tunable microporous architecture (average pore size: 1.26 nm), and abundant functional groups, enabling selective enrichment of small peptides while excluding larger proteins [Figure 12H and I]. The rich nitrogen-containing groups support hydrophilic interactions for glycopeptide capture, while iron ions serve as coordination sites for phosphorylated peptides. Under optimized conditions (90% ACN, 1% TFA), it simultaneously enriched 4 endogenous phosphopeptides and 41 N-glycopeptides from human serum, demonstrating its capability in integrated analysis of PTMs with high selectivity and applicability. A considerable number of glycopeptides and phosphopeptides could still be detected, with their signal intensities remaining at a high level. This confirms that the material has excellent room-temperature storage stability [Figure 12J and K].
COF and its derivatives provide an efficient, sensitive, and controllable new strategy for the simultaneous enrichment of glycopeptides and phosphorylated peptides, which greatly promotes the joint omics study of PTMs of multiple proteins in complex biological samples.
Separation of proteins
Protein separation is of great importance in the life sciences, medicine, and food industry. Isolation and purification of proteins is a prerequisite for studying their structure and function, and only by obtaining high-purity proteins can their biological activity, enzymatic properties, and interactions with other molecules be accurately analyzed[141].
By precisely designing the type of junction in the COF structure, the pore size can be finely tuned, resulting in efficient size-exclusion separations based on protein molecular weight differences[119]. On this basis, according to the charge and hydrophobicity control mechanism, when COF is designed as a cationic
For example, Wang et al. developed two COFs, Azo-COF and Tp-COF, achieving fine-tuned pore sizes of 2.78 and 2.99 nm, respectively [Figure 13A][119]. PXRD confirmed their good crystallinity, with AA stacked models matching experimental data well. SEM revealed rod-shaped crystals, while HRTEM observed lattice fringes consistent with simulation models, indicating clear pore structures [Figure 13B-G]. CLSM images further validated protein adsorption inside the pores rather than on the surface. Model protein separations were performed in vials and in a COF-based device, respectively [Figure 13H and I]. By serially using Azo-COF and Tp-COF with finely tuned pore sizes, size-selective separation of low-molecular-weight proteins can be achieved [Figure 13J and K]. By leveraging size exclusion and weak interactions, this dual-COF system efficiently separates target proteins, achieving a recovery rate exceeding 75% from mixed protein samples. This work underscores the potential of precisely tuned COF structures for enhancing selectivity in protein enrichment by demonstrating effective size-based separation and high specificity for small molecules.
Figure 13. (A) Synthetic routes of Azo-COF and TP COF; (B and E) SEM images of Azo-COF (B) and Tp-COF (E); (C, D, F, G) HRTEM images of Azo-COF (C and D) and Tp-COF (F and G); (H and I) Schematic representation of model proteins separation in vials (H) and COF-based device (I); (J) Proteins separation by the tandem utilization of Azo-COF and Tp-COF: proteins mixture before treatment (1), the supernatant after (1) treated with Azo-COF (2), the supernatant after (2) treated with TpCOF (3), the eluate of Azo-COF (4), and the eluate of Tp-COF (5); (K) Proteins separation by the COF-based device. Proteins mixture before treatment (1), the eluate of Azo-COF-contained filter (2), the eluate of Tp-COF-contained filter (3), and the solution through the COF-based device (4). (A-K) are reprinted with permission from Ref.[119], Copyright © 2022 by Springer Nature. COF: Covalent organic framework; SEM: scanning electron microscope; HRTEM: high-resolution transmission electron microscopy.
Mosleh et al. synthesized Py-BPy-COF using 2,2′-bipyridine (BPy) and pyrene (Py) as building blocks via a Schiff base reaction, followed by modification with quaternary ammonium from 1,2-dibromoethane to obtain positively charged Py-BPy2+−COF for specific separation of amino acid [Figure 14A and B][142]. TEM revealed clear lattice fringes, confirming high crystallinity even after modification [Figure 14C and D]. The quaternary ammonium introduction was aimed at enhancing electrostatic interactions for selective adsorption. Py-BPy2+−COF exhibited significant differences in amino acid adsorption, particularly favoring glutamic acid and aspartic acid due to their negative charges at pH 7.8, which interact strongly with the cationic sites. For proteins, cytochrome c (12 kDa, pI 10.7) showed the highest adsorption capacity of 5,800 μg/mg, attributed to its size and charge compatibility with the material’s pore size of 2.15 nm, allowing adsorption both on the surface and within the pores. In contrast, BSA could only adsorb minimally on the surface due to its larger radius. When tested with protein mixtures, negatively charged and size-matched cytochrome c was preferentially adsorbed, while lysozyme and BSA were excluded due to size or weaker charge interactions. HPLC quantification and SDS-PAGE analysis further validated the highly selective capture of cytochrome c, demonstrating efficient and specific separation [Figure 14E and F].
Figure 14. (A) Adsorption strategies of COFs toward low-molecular-weight biomolecules (amino acids) and adsorption of larger biomolecules (proteins); (B) Synthesis of Py-BPy–COF and transformation of Py-BPy–COF to the cationic Py-BPy2+–COF; TEM characterization of (C) Py-BPy−COF and (D) Py-BPy2+−COF; Selective protein separation using Py-BPy2+−COF, (E) HPLC curves, and (F) SDS-PAGE analysis of protein selectivity assay. (A-F) are reprinted with permission from Ref.[119], Copyright © 2021 by American Chemical Society. COFs: Covalent organic frameworks; Py: pyrene; BPy: 2,2′-bipyridine; TEM: transmission electron microscope; HPLC: high-performance liquid chromatography; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Additionally, functionalizing COFs with GSH enhances protein interactions to improve binding affinity, optimizing separation efficiency. Bettada et al., synthesized a magnetic 3D COF–GSH MIPs material designed for selective protein recognition and separation, particularly aiming to enhance selectivity and applicability in complex biological systems relevant to glycopeptide enrichment[143]. The structure features a Fe3O4 NP core for magnetic responsiveness, a 3D COF layer formed by imine bonding between COOH-1,3,5-triformylphloroglucinol (cTp) and tetra(p-aminophenyl)methane (TAM), and an outer MIP shell using BSA as a template [Figure 15A]. Adsorption experiments showed that the MIPs had a maximum BSA binding capacity of 429 mg/g, significantly higher than the 89 mg/g for non-imprinted polymers (NIPs), with an imprinting factor of 4.79 and separation factors of 2.76-3.68, demonstrating the effectiveness of molecular imprinting and GSH–BSA interactions in achieving selective recognition [Figure 15B]. UV-Vis spectroscopy showed that the supernatant treated with MIPs had lower absorbance at 280 nm than after NIPs, indicating that MIPs adsorbed BSA more efficiently [Figure 15C]. In SDS-PAGE analysis, BSA bands were obvious in L5 (eluent of MIPs), which verified the specific recognition and separation ability of MIPs to BSA, while the adsorption of NIPs was non-specific [Figure 15D]. By integrating magnetic separation, molecular imprinting, and GSH-based affinity, this 3D COF–GSH MIPs system offers a highly selective, stable, and reusable platform for protein separation, aligning well with the design goal of improving selectivity in protein enrichment and showing strong potential for application in complex biological samples.
Figure 15. (A) Preparation of magnetic 3D COF–GSH MIPs; (B) Rebinding selectivity of magnetic 3D COF–GSH MIPs and NIPs for different proteins; (C) UV-Vis analysis and (D) SDS-PAGE analysis for compatibility of magnetic 3D COF–GSH MIPs/NIPs. L1: Marker, L2: PBS with spiked proteins, L3; and L4: supernatant solutions after adsorption with magnetic 3D COF-GSH MIPs and NIPs respectively, L5; and L6: Eluted solutions from magnetic 3D COF-GSH MIPs and NIPs in 0.5% SDS and 0.1% HOAc (1:1) respectively. (A-D) are reprinted with permission from Ref.[143], Copyright © 2022 by Multidisciplinary Digital Publishing Institute. COF: Covalent organic framework; GSH: glutathione; MIPs: molecularly imprinted polymers; NIPs: non-imprinted polymers; UV-Vis: ultraviolet-visible spectroscopy; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; PBS: phosphate-buffered saline; HOAc: acetic acid.
Separation of small molecules
Small-molecule metabolites directly reflect the body’s metabolic status, and their changes are often closely associated with the occurrence and development of diseases, thus being widely used for early disease diagnosis, prognosis evaluation, and therapeutic effect monitoring[144]. COFs have demonstrated high sensitivity, selectivity, and excellent anti-interference ability in the separation, enrichment, and detection of various small-molecule biomarkers. COF-based separation and detection platforms have been applied to complex biological samples such as serum and urine, enabling efficient screening and early diagnosis of disease-related small-molecule markers[145].
COF can be modified with boric acid[146], sulfonic acid[147] and other groups or metal ions[148] to specifically bind to the target small molecule biomarkers, and combined with mass spectrometry, electrochemistry and other detection methods, ultra-sensitive detection of low-abundance biomarkers can be realized.
Dan et al. constructed a core-shell structure (Fe3O4@TtDt@Cu2+) via hydrothermal and Schiff base reactions, with Fe3O4 as the magnetic core and COF as the mesoporous shell, with a specific surface area of 348.1 m2/g [Figure 16A][148]. The triazine ring forms π–π stacking interactions with the aromatic rings in mPAEs, while the nitrogen atom in the imine bond forms hydrogen bonds with the hydrogen atoms in mPAEs. The hydrophobic region of the catechol group interacts hydrophobically with the alkyl chains of mPAEs. The synergistic combination of these multiple interactions significantly enhances the material’s selectivity. This work presents a robust and selective platform for trace mPAE detection in biological samples, enabled by the synergistic integration of magnetic separation, structural porosity, and multifunctional binding mechanisms [Figure 16B].
Figure 16. (A)Schematic representation of the preparation of Fe3O4@TtDt@Cu2+ composites; (B) the MSPE process for mPAEs in mouse plasma samples; (C)Scheme of the NiFe2O4/COF preparation and MSPE procedure for QNs. (A and B) are reprinted with permission from Ref.[148], Copyright © 2023 by Elsevier. (C) is reproduced with permission from Ref.[147], Copyright © 2024 by Elsevier. TtDt: Tt (1,3,5-tris-(4-aminophenyl) triazine)-Dt (2,3- dihydroxyterephthalaldehyde) covalent organic framework; MSPE: magnetic solid-phase extraction; mPAEs: phthalate monoesters; COF: covalent organic framework; QNs: quinolones.
Lin et al. developed a magnetic NiFe2O4/COF composite with a mesoporous structure (pore size: 4.3 nm) and sulfonic acid functional groups, designed for efficient and selective enrichment of small molecules [Figure 16C][147]. The material combines super-paramagnetism (16.5 emu/g) for rapid magnetic separation (< 10 s), a mesoporous framework suitable for molecules ~1 nm in size, and multiple interaction sites - such as electrostatic, hydrogen bonding, and π–π interactions - provided by sulfonic acid groups, which enable a high adsorption capacity of 716.7 mg/g for ciprofloxacin. When applied to the enrichment of quinolones (QNs, ~0.8-1.2 nm), the material demonstrated excellent selectivity by allowing target molecules to diffuse into the pores while blocking larger interferences. Coupled with UHPLC-Q-Orbitrap HRMS, the method achieved a linear range of 0.01-100 ng/g, a low limit of detection (1.1 pg/g), and the recoveries ranged from 82.2% to 108.4% for 18 QNs in complex biological matrices such as pig and chicken viscera.
Additionally, COF nanosheets have also been applied in fluorescent sensing. In 2025, Ma et al. synthesized a Eu3+-functionalized COF (Eu3+@TAB–DFP–COF) via Schiff base reaction[149]. The hexagonal mesoporous structure (pore size ~0.9 nm) retained its crystallinity and porosity after metal coordination, allowing selective molecular diffusion and interaction within the pores. The material enables specific recognition of L-lysine through a combination of electrostatic and hydrogen bonding interactions, as well as chiral spatial matching. Fluorescence response was ratiometrically measured (I468/I614), effectively reducing background interference. The sensor exhibited a linear range of 0.1-130 μM, a detection limit of 17.5 nM, and a selectivity factor of 3.16 for L-lysine over its enantiomer, with recovery rates of 95.9%-103.4% in spiked milk samples. This work demonstrates the potential of functionalized COF nanosheets in selective molecular sensing, particularly for chiral biomolecules, by integrating structural order with tailored recognition sites.
APPLICATION OF HOFS IN BIOSEPARATION
HOFs are a class of novel crystalline porous materials. Their organic building units form framework structures through hydrogen-bonded self-assembly, accompanied by secondary interactions such as van der Waals forces, π–π stacking interactions, and electrostatic interactions, and it is used in various fields[150-153].
Separation of small molecules
Small-molecule biomarker detection serves as a crucial approach in modern biomedical research and disease diagnosis. By monitoring the dynamic changes of small-molecule metabolites in the body, it can reveal the molecular mechanisms underlying disease occurrence and progression, while providing potential biomarkers for the early diagnosis and treatment of diseases. Since most raw materials used for synthesizing HOFs contain conjugated aromatic rings, many HOF materials exhibit fluorescent properties. Especially when the raw materials include the organic building blocks contain mechanisms such as π–π* transitions, which give the material strong fluorescence properties making HOFs show great potential as fluorescent sensing probes[154]. Mechanistically, fluorescence quenching in luminescent materials mainly originates from electron or energy transfer between analytes and emissive units. In HOF-based systems, a pronounced spectral overlap between the HOF emission and analyte absorption enables non-radiative energy transfer, leading to efficient fluorescence attenuation. Meanwhile, fluorescence recovery occurs upon removal or competitive displacement of the quenching species, accompanied by restoration of the electronic structure and ordered framework. Owing to their hydrogen-bond-driven self-assembly, HOFs can spontaneously reconstruct their ordered architectures after external perturbations, suppressing non-radiative decay pathways and thereby restoring fluorescence emission. This reversible on–off luminescence response underpins the utility of HOFs as robust and reusable fluorescent sensing platforms.
Chen et al. developed a HOF, named HOF-BTB, for the highly sensitive fluorescent detection of 3-methoxytyramine (3-MT), a tumor biomarker[155]. Constructed from 1,3,5-tris(4-carboxyphenyl)benzene (H3BTB) through carboxylic acid dimerization and π–π stacking, the material forms a complex framework with a two-dimensional (6,3) honeycomb structure and one-dimensional channels, enabling rapid diffusion and enrichment of 3-MT [Figure 17A and B]. Characterization including PXRD, FT-IR, and SEM confirmed the material’s structural stability and crystallinity, both before and after binding with 3-MT, indicating a non-covalent adsorption mechanism [Figure 17C]. Upon 3-MT addition, the fluorescence peak at 360 nm (HOF-BTB) was quenched, while a new peak at 312 nm emerged and intensified. By using the fluorescence intensity ratio I312/I360 as a ratiometric signal, a sensitive “turn-on” fluorescence sensor was established, achieving a wide linear range and a detection limit as low as 46 nM - superior to most fluorescent sensors and comparable to HPLC. This performance enables efficient detection of 3-MT in clinical urine samples, offering a promising tool for early diagnosis of pheochromocytoma and paraganglioma. Zhang et al. developed a fluorescent sensor based on an iron-modified Fe-HOF for the sensitive detection of ascorbic acid (AA)[156]. Constructed from melamine (MA), BDC-(OH)2, and H3BTC through hydrogen-bonded self-assembly, Fe-HOF features porous structure with redox-active Fe3+ centers coordinated to phenolic hydroxyl groups [Figure 17D]. After Fe3+ modification, it can be seen that partial cracks appear in the original complete filamentous and rod-like structures, indicating that the addition of trivalent iron changes the morphology of the original HOF, but the overall micron rod-like structure did not change [Figure 17E and F]. The material exhibits fluorescence derived from the π–π* transitions of BDC-(OH)2. Upon AA introduction, Fe3+ is reduced to Fe2+, leading to fluorescence recovery at 530 nm, which serves as the detection signal. The fluorescence intensity ratio (F/F0) shows a linear response to AA concentrations from 0.5 to 8 μM, with a low detection limit of 0.14 μM - well below physiological AA levels - enabling sensitive detection in complex matrices. When there are multiple coexisting substances (such as Na+, lysine, GSH, etc.), the fluorescence intensity ratio (F/F0) is almost unnoticed. And when AA is added, the rate increases significantly [Figure 17G]. AA Fe-HOF was successfully applied to AA quantification in vitamin C tablets with high accuracy (RSD = 2.1%). Its porous structure, redox activity, and fluorescence recovery mechanism make it a promising platform for biosensing. Similarly, Chen et al. reported a multi-responsive fluorescent HOF material, HOF-PyTTA, synthesized via solvent diffusion[154]. Fluorescence is quenched by Fe3+ ions and subsequently restored upon binding with GSH, enabling selective GSH detection based on fluorescence recovery. This system highlights the versatility of HOFs in designing stimuli-responsive fluorescent sensors for small biomolecules.
Figure 17. (A and B) HOF-BTB has complex eight-fold interpenetrating structure; (B) HOF-BTB exhibits one-dimensional channels in the frame; (C) Different urine interfering substances were added to HOF-BTB with its SEM image; (D) The synthesis route of Fe-HOF and the experimental principle of Fe-HOF used in the detection of ascorbic acid; (E and F) SEM images of Fe-HOF at different magnifications; (G) Fluorescence response of HOF based assay system toward various coexisting species, including Na+, Ca2+, Zn2+, SO42-, Mg2+, K+, and Cl- (1 mM), Lys, Glu, Thr, His, Ala, and Leu (100 μM), AA, L-Cys, and GSH (5 μM). (A-C) are reprinted with permission from Ref.[148], Copyright © 2023 by Academic Press Inc Press. (D-G) are reproduced with permission from Ref.[147], Copyright © 2024 by Elsevier. HOF: Hydrogen-bonded organic framework; BTB: 1,3,5-tris (4-carboxyphenyl) benzene; SEM: scanning electron microscope; Lys: lysine; Glu: glutamic acid; Thr: threonine; His: histidine; Ala: alanine; Leu: leucine; Cys: cysteine; GSH: glutathione.
Sahoo et al. developed a three-dimensional porous HOF, named HOF (IITKGP-HOF-6), using the tetradentate carboxylic acid ligand 5-(bis(4-carboxyphenyl)amino)isophthalic acid (H4L) [Figure 18][157]. The framework’s benzene rings and carboxylic acid groups form a stable network through hydrogen bonding, creating twisted tetrahedral conformations with dihedral angles of 43° and 82°, which establish 1D nanochannels along the a-axis (6.8 × 6.8 Å2). This structure, confirmed by XRD and PLATON analysis showing 28% solvent-accessible volume, exhibits excellent water and air stability, as evidenced by unchanged PXRD patterns after immersion in water for 7 days or exposure to air for 15 days. The material’s hydrophilic microporous structure, demonstrated by its high water vapor adsorption capacity (75 mg/g at 298 K), and thermal stability up to 250 °C make it ideal for capturing targets in aqueous solutions. H4L shows strong fluorescence emission at 480 under 360 nm excitation, which is significantly quenched upon binding nitrofuran antibiotics (NFZ and NFT) due to hydrogen bonding and π–π interactions, achieving a quenching efficiency of 84%. Specifically, the binding energy between NFZ and HOF reaches -34.5 kcal/mol, significantly higher than other antibiotics, leading to a low detection limit of 0.75 μM. HOF (IITKGP-HOF-6) demonstrates high sensitivity and reliability for real-world water sample testing, providing a robust platform for on-site monitoring of antibiotic residues in environmental water.
Figure 18. A water-stable HOF (IITKGP-HOF-6) for aqueous medium antibiotic sensing for NFT and NFZ. Reprinted with permission from Ref.[157], Copyright © 2025 by Wiley. HOF: Hydrogen-bonded organic framework.
What’s more, many HOFs are used for the separation and detection of small molecules. For example, FJU-360 is employed to detect aniline[158], HOF-DBA is used for the detection of γ-aminobutyric acid and nitrofurazone[159], Eu@HOF-GS-10 is used for the detection of quinolone antibiotics (QNs)[160].
Separation of biomacromolecules
A biomarker is a measurable biological indicator that can be used as a potential index for evaluating normal or abnormal pathophysiological states or the pharmacological response to specific therapeutic regimens, and can be detected and quantified[161]. Molecular biomarkers cover a wide range from small molecules to macromolecules, including peptides, proteins, lipid metabolites, nucleic acids (DNA and RNA), etc., and can be applied to disease diagnosis, prognostic assessment, therapeutic monitoring, and disease mechanism research[162-165].
Li et al. constructed a luminescent HOF (Lumi-HOF@Tb) by assembling four hydrogen-bonding ligands–melamine (MA), cyanuric acid (CA), luminol, and H3BTC– and incorporating Tb3+ ions to form a luminescent center [Figure 19][166]. The resulting 3D HOF features a regular nanocylinder morphology
Figure 19. Scheme illustration of the dual-signal optical sensor based on Lumi-HOF@Tb for α-glucosidase detection. It was synthesized at room temperature and modified with Tb3+, integrates fluorescence and chemiluminescence for dual-signal detection of α-glucosidase activity. By monitoring fluorescence recovery at 546 nm (Tb3+) and H2O2-driven chemiluminescence, the sensor enables selective and sensitive detection, showcasing its potential in biosensing and enzyme inhibitor screening. Reprinted with permission from Ref.[166], Copyright © 2022 by American Chemical Society. HOF: Hydrogen-bonded organic framework.
As two important PTMs, protein phosphorylation and glycosylation play a key role in cell signaling and disease diagnosis, but traditional methods struggle to enrich multiple PTMs simultaneously, especially monophosphorylated peptides that are often overlooked due to low affinity. Thus Xiong et al. developed a dual-ligand Fe3O4@HOF for the simultaneous enrichment of mono-phosphopeptides and glycopeptides[163]. The framework is constructed via hydrogen bonding and electrostatic interactions between guanidine cations and borate anions, with superparamagnetic Fe3O4 NPs embedded for easy separation and recycling [Figure 20A]. Guanidine (GD) and boric acid (BA) are connected through hydrogen bonds (marked with blue dashed lines) to form a “guanidine-boric acid” synergistic unit [Figure 20B and C]. This unit not only enhances the structural stability of the HOF but also endows it with dual recognition capabilities for phosphopeptides and glycopeptides, respectively. In addition, the positive and negative charge regions in the HOF structure are evenly distributed and exhibit strong complementarity [Figure 20D]. The saturated adsorption isotherms of Fe3O4@HOF for phosphate ions and glycogen showed that the adsorption equilibrium of both was achieved within 5 min, and the maximum adsorption capacity for phosphate ions was higher than that for glycogen. This confirms the material’s efficient adsorption capacity for these two simulated target molecules [Figure 20E]. Fe3O4@HOF demonstrated exceptional performance in complex biological samples: it detected mono-phosphopeptides at 4 × 10-10 M even in the presence of a 1,000-fold excess of BSA, and enriched glycopeptides from HRP digests down to 2 × 10-10 M, with 17 highly abundant glycopeptides specifically enriched from HRP/BSA mixtures (1:1,000). Fe3O4@HOF was applied to the enrichment of glycopeptides and phosphopeptides in the serum of lung cancer patients and healthy people, and the results showed that 51 proteins in both groups of serum had both glycosylation and phosphorylation modifications, and more than 90% of the phosphopeptides were mono-phosphopeptides, verifying the high selectivity of the material for mono-phosphopeptides [Figure 20F and G]. PCA and heat maps show that the phosphorylated and glycosylated protein expressions in the two groups are clearly differentiated, and this material can be used to distinguish lung cancer patients from healthy people, providing a basis for disease-related PTM studies [Figure 20H-K].
Figure 20. (A) Fabrication process of Fe3O4@HOF; (B) Schematic illustration of HOF comprising borate ester anion and guanidinium cation via H-bonding (highlighted by dashed blue line with disordered Cl- omitted for clarity); (C) Calculated electron density map of HOF (red, negative part; blue, positive part); (D) H-bonding (denoted as dashed blue line) between GD and BA; (E) Saturated adsorption isotherms for phosphate and glycogen adsorbed by Fe3O4@HOF; (F) Venn diagram of the overlap of glycosylation and phosphorylation at the protein level; (G) Distribution of mono-, and multi-phosphorylation events observed from human serum samples of lung cancer patients and healthy controls; Quantitative PCA of (Group A) healthy controls and (Group B) lung cancer patients of (H) phosphoproteins and (I) glycoproteins; Heat maps of the significantly regulated proteins between (Group A) healthy controls and (Group B) lung cancer patients of (J) phosphoproteins and (K) glycoproteins. Reprinted with permission from Ref.[163], Copyright © 2024 by Elsevier. HOF: Hydrogen-bonded organic framework; GD: guanidine hydrochloride; BA: boric acid; PCA: principal component analysis.
Chen et al. successfully prepared a DS-HOF by self-assembling TAM and 4,4′-dithiobisbenzoic acid (DTBA) through intermolecular hydrogen bonding[165]. This material enables efficient encapsulation and intracellular delivery of functional proteins, with over 95% encapsulation efficiency for model protein GFP [Figure 21A] The disulfide bonds (-S-S-) in DTBA render DS-HOF responsive to high levels of GSH in cancer cells, enabling selective degradation and controlled protein release. In vitro studies showed that 75% of the encapsulated GFP was released within 12 h under GSH-rich conditions. The size of DS-HOF NPs can be tuned by adjusting the TAM:DTBA ratio, with a 1:4 molar ratio yielding uniform spherical NPs (~100 nm). This size of the material favors cellular internalization, enabling tumor-targeted accumulation. Structural and morphological characterizations (SEM, TEM, PXRD) confirmed that protein loading had minimal impact on the framework’s integrity, preserving its crystallinity and porosity. DS-HOF exhibits excellent biocompatibility and efficient cellular uptake, with over 90% internalization efficiency in HeLa cells and cytoplasmic delivery confirmed by GFP fluorescence. To observe the degradation effect of DS-HOF delivery of bacterial effector protein DUF5 on mutant RAS. Western blot results showed that HCT-116 cells were treated with DUF5@DS-HOF, RAS degradation, p-ERK1/2 downregulation, and cell growth was inhibited [Figure 21B]. When loaded with DUF5, a protein degrader of mutant RAS, DS-HOF effectively reduced RAS levels, inhibited p-ERK1/2 signaling, and suppressed HCT116 cell viability to 40% in vitro, with tumor volume reduced to 20% of the control group [Figure 21C]. Experiments on tumor-bearing mice showed that DUF5@DS-HOF could reduce the tumor volume to only 20% of that in the PBS group [Figure 21D and E]. TUNEL and H&E staining showed that the apoptosis of tumor cells in the DUF5@DS-HOF-treated group was obvious. It was verified that DS-HOF efficiently delivers DUF5 to the cytosol and inhibits tumor growth by degrading mutant RAS [Figure 21F]. These features, combined with low in vitro and in vivo toxicity, highlight DS-HOF as a promising platform for targeted protein delivery in cancer therapy.
Figure 21. (A) Schematic illustration of the self-assembly of bio-reducible DS-HOF for intracellular protein delivery and mutant RAS signaling rewiring in cancer cells; (B) Western blot assay of RAS and p-ERK1/2 in HCT-116 cells following the treatment of DUF5@DS-HOF and DUF5@TAHOF NPs (DUF5 concentration: 400 nM); (C) DUF5@DSHOF delivery prohibited HCT-116 cell growth. HCT-116 cells were treated with GFP@DS-HOF or DUF5@DS-HOF at indicated concentrations before cell viability assay; (D) Tumor volume of HCT-116 tumor-bearing mice received different injections as indicated. Data are presented as means ± SD (n = 5); (E) Western blot assay of RAS and p-ERK1/2 in tumors harvested from mice that received different DUF5 and NP treatments; (F) TUNEL analysis (for cell apoptosis) and H&E staining of tumor tissues harvested from mice received different treatments as indicated. Scale bar: 100 μm. Reprinted with permission from Ref.[165], Copyright © 2023 by American Chemical Society. DS: Disulfide; HOF: hydrogen-bonded organic framework; RAS: rat sarcoma viral oncogene homolog; p-ERK: phosphorylated extracellular signal-regulated kinase; HCT: human colon tumor; DUF5: domain of unknown function 5; NPs: nanoparticles; GFP: green fluorescent protein; SD: standard deviation; TUNEL: terminal deoxynucleotidyl transferase dUTP nick-end labeling.
Encapsulating proteins in HOF materials not only protects biomolecule activity and improves detection performance, but also expands functional boundaries through material-biomolecule synergies. What’s more, there are also many HOFs used to encapsulate proteins, such as BioHOF-1[167], enzyme@TaTb[168]. Moreover, HOFs have the greatest potential in bioseparation due to their excellent biocompatibility, mild synthesis conditions, and reversible self-assembly. Unlike MOFs, which may contain metal residues, and COFs, which are sensitive to water, HOFs are composed of small organic molecules and can be synthesized under mild, aqueous conditions. Their self-assembly allows for easy recovery and reusability, making them ideal for applications involving small-molecule drugs, natural products, or sensitive biomolecules. These properties make HOFs highly promising for bioseparation.
CONCLUSION AND OUTLOOK
In summary, porous framework materials - including MOFs, COFs, and HOFs - have emerged as highly effective platforms for bioseparation. Their tunable porosity[169-172], high surface areas[173-177], and versatile surface chemistry collectively enable selective recognition and efficient enrichment of a wide range of biomolecules, ranging from proteins, phospho- or glyco-peptides[100] to small molecules, displaying clear advantages over conventional separation media. Nevertheless, their practical application in complex biological environments still faces significant challenges. The most urgent bottlenecks hindering the practical application of porous framework materials lie in three core dimensions: scalable synthesis, structural stability, and cost-effectiveness. MOFs often rely on expensive high-purity organic ligands and metal precursors, and their conventional solvothermal syntheses suffer from high energy consumption, large solvent usage, and poor batch-to-batch reproducibility. Moreover, many MOFs are susceptible to hydrolysis or structural degradation under humid or acidic/alkaline conditions; even robust variants such as Zr-based MOFs frequently lack sufficient mechanical strength for long-term operation. COFs, while metal-free and highly designable, typically require stringent anhydrous and oxygen-free conditions for synthesis, and their dynamic covalent linkages (e.g., imine or boronate ester bonds) remain vulnerable to hydrolysis, limiting durability in real-world environments. HOFs, constructed solely through reversible hydrogen bonds, offer advantages in processability and biocompatibility but exhibit inherently low thermal and chemical stability, often disassembling in the presence of moisture, heat, or competitive solvents. Furthermore, the multi-step organic syntheses required for tailored building blocks in all three classes contribute to high material costs and environmental burdens. Together, these intertwined limitations in scalability, stability, and economics represent a major barrier to the industrial translation of MOFs, COFs, and HOFs beyond laboratory-scale demonstrations.
Herein, our work provides initial insights into structure–performance relationships but remains limited in scope. Notably, the correlations identified here have not yet been validated through high-throughput experimental or computational screening across diverse structural parameters. Future efforts should expand these relationships into comprehensive, standardized datasets that capture the influence of pore geometry, functional group chemistry, framework flexibility, and environmental conditions on separation performance. Such datasets would be well-suited for integration with machine learning models, enabling data-driven prediction and rational design of next-generation porous framework materials. By coupling mechanistic understanding with artificial intelligence, the development cycle for high-performance MOFs, COFs, and HOFs could be dramatically accelerated - ultimately bridging the gap between fundamental discovery and industrial application.
Looking forward, the next generation of porous materials will be characterized by multifunctional integration, mechanistic synergy, and intelligent design[25]. The convergence of advanced characterization techniques, computational modeling, and data-driven optimization will deepen our understanding of host–guest interactions and guide rational material engineering. By integrating multiple separation mechanisms - such as affinity, ion exchange, and size exclusion - into a single platform[178,179], while enhancing biocompatibility and stimuli-responsiveness, these “smart” materials will enable adaptive purification strategies. Emerging classes of porous frameworks - including supramolecular organic frameworks (SOFs), halogen-bonded organic frameworks (XOFs), and crystalline porous organic salts (CPOS) - offer highly tunable structures, dynamic responsiveness, and precisely engineered host–guest chemistry, opening new frontiers in bioseparation. These innovations hold significant promise for transformative applications in precision medicine[180], point-of-care diagnostics[181], and cell therapy[182], driving progress across biotechnology and biomedical engineering.
DECLARATIONS
Acknowledgments
The copyrighted small icons in the graphic abstract were reproduced with permission from Ref.[125], Copyright © 2022 by Elsevier and with permission from Ref.[148], Copyright © 2023 by Elsevier, the relevant copyright regulations were strictly observed. The other small icons in graphic abstract are original works created independently by the authors.
Authors’ contributions
Prepared the manuscript: Liu, C.; Wang, Y.
Supervised and revised the manuscript: Sheng, Q.
Corrected the manuscript: Qing, G.
Availability of data and materials
Not applicable.
AI and AI-assisted tools statement
During the preparation of this manuscript, the AI tool Doubao-1.5-pro (released 2025-01-22) was used solely for language editing. The tool did not influence the study design, data collection, analysis, interpretation, or the scientific content of the work. All authors take full responsibility for the accuracy, integrity, and final content of the manuscript.
Financial support and sponsorship
This work was supported by the National Key R&D Program of China (Grant No. 2022YFC3400800), the National Natural Science Foundation of China (22174138 and 22104013), DICP Innovation Funding (DICP-I202243 and I202229), DMU-1&DICP UN202303, DMU-1&DICP UN202307 and DMU-2&DICP UN202504, and the Natural Science Foundation of Shanghai (25ZR1402105).
Conflicts of interest
All authors declared that there are no conflicts of interest.
Ethical approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Copyright
© The Author(s) 2026.
REFERENCES
1. Kaliaraj, G. S.; Shanmugam, D. K.; Dasan, A.; Mosas, K. K. A. Hydrogels-A promising materials for 3D printing technology. Gels 2023, 9, 260.
2. Zhao, H.; Zhang, Y.; Hua, D. A review of research progress in microfluidic bioseparation and bioassay. Micromachines 2024, 15, 893.
3. Buarque, F.; Gautério, G.; Coelho, M.; Lemes, A.; Ribeiro, B. Aqueous two-phase systems based on ionic liquids and deep eutectic solvents as a tool for the recovery of non-protein bioactive compounds - a review. Processes 2023, 11, 31.
4. Khunnonkwao, P.; Thitiprasert, S.; Jaiaue, P.; Khumrangsee, K.; Cheirsilp, B.; Thongchul, N. The outlooks and key challenges in renewable biomass feedstock utilization for value-added platform chemical via bioprocesses. Heliyon 2024, 10, e30830.
5. Feng, L.; Wang, X.; Guo, X.; et al. Identification of novel target DCTPP1 for colorectal cancer therapy with the natural small-molecule inhibitors regulating metabolic reprogramming. Angew. Chem. Int. Ed. Engl. 2024, 63, e202402543.
6. Ponjavic, M.; Malagurski, I.; Lazic, J.; et al. Advancing PHBV biomedical potential with the incorporation of bacterial biopigment prodigiosin. Int. J. Mol. Sci. 2023, 24, 1906.
7. Santana-Mayor, A.; Rodríguez-Ramos, R.; Herrera-Herrera, A.; Socas-Rodríguez, B.; Rodríguez-Delgado, M. Updated overview of QuEChERS applications in food, environmental and biological analysis (2020-2023). TrAC. Trends. Anal. Chem. 2023, 169, 117375.
8. Shi, Z.; Zhang, X.; Yang, X.; et al. Specific clearance of lipopolysaccharide from blood based on peptide bottlebrush polymer for sepsis therapy. Adv. Mater. 2023, 35, e2302560.
9. Sun, W.; You, X.; Zhao, X.; et al. Precise capture and dynamic release of circulating liver cancer cells with dual-histidine-based cell imprinted hydrogels. Adv. Mater. 2024, 36, e2402379.
10. Sun, S.; Zhang, Y.; Wang, M.; et al. Design and fabrication of glass metal–organic framework membrane for gas separation. Ind. Eng. Chem. Res. 2025, 64, 14771-88.
11. Wang, D.; Xiong, Y.; Sheng, Q.; Huang, Y.; Qing, G. Theoretical calculations in separation science for analytical chemistry: applications and insights. Chem. Asian. J. 2025, 20, e202500006.
12. Wang, S.; Yin, L.; Ju, Y. Multi-objective optimization of a cascade system for 136Xe enrichment via microchannel distillation. Energy 2025, 337, 138702.
13. Jamal, Q. M. S.; Ahmad, V. Bacterial metabolomics: current applications for human welfare and future aspects. J. Asian. Nat. Prod. Res. 2025, 27, 207-30.
14. Zhou, J.; Li, X.; Zhang, Z.; et al. Bio-based and bio-degradable nanofiber materials: a sustainable platform for energy, environmental, and biomedical applications. Chem. Eng. J. 2024, 491, 152105.
15. Zhang, F.; Xu, K.; Bai, Y.; Wang, P. Multifunctional cellulose paper-based materials. Cellulose 2023, 30, 8539-69.
16. Zhao, K. X.; Zhang, G. Q.; Wu, X. R.; et al. Proton conduction in zirconium-based metal-organic frameworks for advanced applications. ACS. Appl. Electron. Mater. 2025, 7, 3164-75.
17. Tang, K.; Chen, Y.; Zhao, Y. Exploiting halide perovskites for heavy metal ion detection. Chem. Commun. 2024, 60, 4511-20.
18. Bhosale, R.; Bhosale, S.; Vadiyar, M.; Jambhale, C.; Nam, K.; Kolekar, S. Recent progress on functional metal–organic frameworks for supercapacitive energy storage systems. Energy. Tech. 2023, 11, 2300147.
19. Li, D.; Yadav, A.; Zhou, H.; Roy, K.; Thanasekaran, P.; Lee, C. Advances and applications of metal-organic frameworks (MOFs) in emerging technologies: a comprehensive review. Glob. Chall. 2024, 8, 2300244.
20. Yang, H.; Liang, G.; Sun, X.; Wu, S. A review on the adsorption of volatile organic compounds by biomass-based porous carbon (BPC) and its mechanism. Carbon. Lett. 2024, 34, 1851-75.
21. Sam, D. K.; Cao, Y. Porous carbon materials for adsorption: a mini-review. Fullerenes. Nanotubes. Carbon. Nanostruct. 2024, 32, 721-32.
22. Wang, D.; Yao, H.; Ye, J.; Gao, Y.; Cong, H.; Yu, B. Metal-organic frameworks (MOFs): classification, synthesis, modification, and biomedical applications. Small 2024, 20, e2404350.
23. Wang, Z.; Zuo, Q.; Wu, X.; et al. Nanoarchitectonics of phloroglucinol-based porous organic materials and their application for environmental pollution. Rev. Environ. Contam. Toxicol. 2025, 263, 18.
24. Zheng, J.; Lan, D.; Zhang, S.; et al. Zeolite imidazolate framework derived efficient absorbers: from morphology modulation to component regulation. J. Alloys. Compd. 2025, 1010, 177092.
25. Wang, A.; Ma, Y.; Zhao, D. Pore engineering of porous materials: effects and applications. ACS. Nano. 2024, 18, 22829-54.
26. Shao, G.; Huang, X.; Shen, X.; Li, C.; Thomas, A. Metal-organic framework and covalent-organic framework-based aerogels: synthesis, functionality, and applications. Adv. Sci. 2024, 11, e2409290.
27. Jin, Y. H.; Li, M. H.; Yang, Y. W. Covalent organic frameworks for membrane separation. Adv. Sci. 2025, 12, e2412600.
28. Liu, Y.; Chen, L.; Yang, L.; et al. Porous framework materials for energy & environment relevant applications: a systematic review. Green. Energy. Environ. 2024, 9, 217-310.
29. Hu, L.; Zhou, Y.; Gong, Y.; Luo, Y.; Liu, X.; Jiang, Z. Microalgal proteins for a circular bioeconomy: nutritional, material, and chemical valorization. Bioresour. Technol. 2025, 436, 133049.
30. Swinnen, S.; de Azambuja, F.; Parac-Vogt, T. N. From nanozymes to multi-purpose nanomaterials: the potential of metal-organic frameworks for proteomics applications. Adv. Healthc. Mater. 2025, 14, e2401547.
31. Pang, J.; Jiang, W.; Zhang, X.; et al. Recent progress in metal-organic frameworks (Part II - material application). Sci. China. Chem. 2025, 68, 1642-702.
32. Yang, M.; Xiao, L.; Chen, W. T.; Deng, X.; Hu, G. Recent advances on metal-organic framework-based electrochemical sensors for determination of organic small molecules. Talanta 2024, 280, 126744.
33. Rajput, S. K.; Mothika, V. S. Powders to thin films: advances in conjugated microporous polymer chemical sensors. Macromol. Rapid. Commun. 2024, 45, e2300730.
34. Zhang, Y.; Zhao, X.; Qing, G. Smart polymers advance analytical chemistry. TrAC. Trends. Anal. Chem. 2025, 187, 118198.
35. Agamendran, N.; Uddin, M.; Yesupatham, M. S.; et al. Nanoarchitectonics design strategy of metal-organic framework and bio-metal-organic framework composites for advanced wastewater treatment through adsorption. Langmuir 2024.
36. Zhang, Q.; Huang, Y.; Dai, Z.; et al. Covalent organic framework membranes: synthesis strategies and separation applications. ACS. Appl. Mater. Interfaces. 2025, 17, 27605-28.
37. Dong, H.; Qu, C.; Li, C.; et al. Recent advances of covalent organic frameworks-based photocatalysts: principles, designs, and applications. Chin. J. Catal. 2025, 70, 142-206.
38. Zhu, L.; Cao, Y.; Xu, T.; et al. Covalent organic framework membranes for energy storage and conversion. Energy. Environ. Sci. 2025, 18, 5675-739.
39. Liu, X.; Zhao, D.; Wang, J. Challenges and opportunities in preserving key structural features of 3D-printed metal/covalent organic framework. Nanomicro. Lett. 2024, 16, 157.
40. Hu, S.; Zhao, H.; Liang, M.; Hao, J.; Xue, P. Interconversion and functional composites of metal-organic frameworks and hydrogen-bonded organic frameworks. Chem. Commun. 2024, 60, 8140-52.
41. Chauhan, A.; Kumar, R.; Raizada, P.; et al. Novel hydrogen-bonded organic framework (HOF) for highly efficient photocatalysis: from structural designs to multifunctional applications. Coord. Chem. Rev. 2025, 535, 216634.
42. Chen, C.; Shen, L.; Lin, H.; Zhao, D.; Li, B.; Chen, B. Hydrogen-bonded organic frameworks for membrane separation. Chem. Soc. Rev. 2024, 53, 2738-60.
43. Martínez-Fernández, M.; Hartmann, Y.; Schmidt, B. M. Porous organic cages as building blocks for framework materials. Angew. Chem. Int. Ed. Engl. 2025, 64, e202509618.
44. Xiong, Y.; Li, M.; Liu, Y.; Liang, X.; Qing, G. Enrichment driven glycoproteomics: new materials, new methods, and beyond. TrAC. Trends. Anal. Chem. 2023, 168, 117290.
45. Johnson, T. F.; Conti, M.; Iacoviello, F.; et al. Evaluating 3D-printed bioseparation structures using multi-length scale tomography. Anal. Bioanal. Chem. 2023, 415, 5961-71.
46. Liu, X.; Wang, C.; Chen, C.; et al. Recent advances in hierarchical porous materials for CO2 capture and utilization. Coord. Chem. Rev. 2025, 544, 216927.
47. Wang, X.; Wang, Y.; Chen, L.; Xie, X.; Sun, J. Gel-state MOFs for environmental decontamination: synthesis, application and optimization. Chem. Eng. J. 2024, 499, 156241.
48. Girigoswami, K.; Pallavi, P.; Girigoswami, A. Crafting porous nanoscaled architecture as a potential frontier for drug delivery. Mol. Syst. Des. Eng. 2024, 9, 1085-106.
49. Liu, W.; Liu, Q.; Wang, D.; Tang, B. Z. Fluorescent porous materials based on aggregation-induced emission for biomedical applications. ACS. Nano. 2024, 18, 27206-29.
50. Hisaki, I.; Fujii, T.; Oketani, R. Supramolecular synthons, tectons, and crystal structures of noncovalent organic frameworks. Chem. Phys. Rev. 2024, 5, 041304.
51. Bigham, A.; Islami, N.; Khosravi, A.; Zarepour, A.; Iravani, S.; Zarrabi, A. MOFs and MOF-based composites as next-generation materials for wound healing and dressings. Small 2024, 20, e2311903.
52. Jacob, E.; Mathew, D.; Benny, L.; Varghese, A. Emerging nanomaterials as versatile nanozymes: a new dimension in biomedical research. Top. Curr. Chem. 2024, 382, 28.
53. Su, P.; Wang, Z.; Li, X.; et al. Fabrication of magnetic dual-hydrophilic metal organic framework for highly efficient glycopeptide enrichment. Anal. Bioanal. Chem. 2021, 413, 5267-78.
54. Yan, S.; Luo, B.; He, J.; Lan, F.; Wu, Y. Phytic acid functionalized magnetic bimetallic metal-organic frameworks for phosphopeptide enrichment. J. Mater. Chem. B. 2021, 9, 1811-20.
55. Griffin, S. L.; Wilson, C.; Forgan, R. S. Uncovering the structural diversity of Y(III) naphthalene-2,6-dicarboxylate MOFs through coordination modulation. Front. Chem. 2019, 7, 36.
56. Wang, Y. M.; Lin, J. T.; Ning, G. H.; Li, D. Recent advances in metal-organic frameworks for catalysing organic transformation. Chem. Commun. 2025, 61, 7563-72.
57. Xin, Y.; Cao, Y.; Yang, J.; Guo, X.; Shen, K.; Yao, W. Mesopore and macropore engineering in metal–organic frameworks for energy environment-related applications. J. Mater. Chem. A. 2024, 12, 4931-70.
58. Mu, A. U.; Cai, G.; Chen, Z. Metal-organic frameworks for the enhancement of lithium-based batteries: a mini review on emerging functional designs. Adv. Sci. 2024, 11, e2305280.
59. Huang, Z.; Noh, J.; Yu, S.; et al. Metal‐organic frameworks for electrolytes and interfaces in rechargeable batteries: from liquid to solid‐state systems. Adv. Energy. Mater. 2025, 15, e02809.
60. Loloei, M.; Kaliaguine, S.; Rodrigue, D. Postsynthetic modification of Zn/Co-ZIF by 3,5-diamino-1,2,4-triazole for improved MOF/polyimide interface in CO2–selective mixed matrix membranes. Ind. Eng. Chem. Res. 2022, 61, 13242-55.
61. Chang, Y.; Shao, J.; Zhao, X.; et al. Precise AIE-based ternary co-assembly for saccharide recognition and classification. Adv. Sci. 2024, 11, e2405613.
62. Wang, J.; Li, M.; Zhang, C.; et al. Identification of isomerically diverse ginsenosides using engineered aerolysin nanopore via non-translocation blockade sensing. Angew. Chem. Int. Ed. Engl. 2025, 64, e202506741.
63. Xiong, Y.; Li, M.; Cao, Y.; et al. Nanofluidic device for detection of lysine methylpeptides and sensing of lysine methylation. Anal. Chem. 2023, 95, 7761-9.
64. Wang, H.; Zhang, X.; Wang, D.; et al. Affinity peptide ligands: new tools for chasing non-canonical N-phosphoproteome. Chem. Sci. 2025, 16, 9290-302.
65. Liu, Z.; Zeng, Y.; Long, L.; Li, Y.; Zhou, W. Lightweight UiO-66 MOF/CNT composites achieving high electromagnetic wave absorption. Diam. Relat. Mater. 2025, 157, 112500.
66. Zhang, Z.; Wang, Z.; Dong, M.; Zhu, Q.; Hyldgaard Klausen, L. Synergistic enhancement of supercapacitors with cobalt–copper bimetal–organic framework. Adv. Eng. Mater. 2024, 26, 2400378.
67. Kumar, R.; Shafique, M. S.; Chapa, S. O. M.; Madou, M. J. Recent advances in MOF-based materials for biosensing applications. Sensors 2025, 25, 2473.
68. Tu, T. N.; Tran, N. T.; Nguyen, Q. H.; Le, V. N.; Kim, J. Metal–organic frameworks for aromatic-based VOC decomposition. Korean. J. Chem. Eng. 2024, 41, 2461-76.
69. Chen, J. K.; Xu, N. Y.; Guo, P.; et al. A chiral metal‐organic framework core‐shell microspheres composite for high‐performance liquid chromatography enantioseparation. J. Sep. Sci. 2021, 44, 3976-85.
70. Yu, Y.; Yuan, B.; Hu, C.; et al. Homochiral metal–organic framework [Co(L)(bpe)2(H2O)2]·H2O used for separation of racemates in high-performance liquid chromatography. J. Chromatogr. Sci. 2021, 59, 355-60.
71. Alzamly, A.; Bakiro, M.; Hussein Ahmed, S.; Alnaqbi, M. A.; Nguyen, H. L. Rare-earth metal–organic frameworks as advanced catalytic platforms for organic synthesis. Coord. Chem. Rev. 2020, 425, 213543.
72. Wang, C.; Wan, Y.; Yang, S.; et al. Revealing the untapped potential of photocatalytic overall water splitting in metal organic frameworks. Adv. Funct. Mater. 2024, 34, 2313596.
73. Flores, C. V.; Machín-Garriga, A.; Obeso, J. L.; et al. Room-temperature synthesis of bimetallic ZnCu-MOF-74 as an adsorbent for tetracycline removal from an aqueous solution. Dalton. Trans. 2024, 53, 18917-22.
74. Mondal, S.; Pramanik, B.; Sahoo, R.; Das, M. C. A chemically robust 2D Ni-MOF as an efficient heterogeneous catalyst for one-pot synthesis of therapeutic and bioactive 2-amino-3-cyano-4H-pyran derivatives. ChemSusChem 2025, 18, e202401248.
75. Hu, Z.; Chen, Z.; Chen, X.; Wang, J. Advances in the adsorption/enrichment of proteins/peptides by metal–organic frameworks-affinity adsorbents. TrAC. Trends. Anal. Chem. 2022, 153, 116627.
76. Wang, B.; Yan, Y.; Ding, C. F. Metal organic frameworks as advanced adsorbent materials for separation and analysis of complex samples. J. Chromatogr. A. 2022, 1671, 462971.
77. Jiang, D.; Qi, R.; Wu, S.; Li, Y.; Liu, J. Preparation of polyoxometalate modified magnetic metal–organic framework and application to the enrichment of phosphopeptides. Microchem. J. 2024, 201, 110510.
78. Jiang, D.; Qi, R.; Wu, S.; Li, Y.; Liu, J. Polyoxometalate functionalized magnetic metal-organic framework with multi-affinity sites for efficient enrichment of phosphopeptides. Anal. Bioanal. Chem. 2024, 416, 4289-99.
79. Qi, H.; Chen, G.; Jia, Q. Metal-organic framework-mediated synthesis of hierarchical layered double hydroxide for high-efficiency enrichment of phosphopeptides. Talanta 2022, 247, 123563.
80. Eivazzadeh-Keihan, R.; Bahreinizad, H.; Amiri, Z.; et al. Functionalized magnetic nanoparticles for the separation and purification of proteins and peptides. TrAC. Trends. Anal. Chem. 2021, 141, 116291.
81. Zhang, B.; Guo, M.; Wang, H.; et al. Metal organic framework nanomaterial-based extraction and proteome analysis of membrane and membrane-associated proteins. Anal. Chem. 2021, 93, 15922-30.
82. Le, T. D.; Suttikhana, I.; Ashaolu, T. J. State of the art on the separation and purification of proteins by magnetic nanoparticles. J. Nanobiotechnol. 2023, 21, 363.
83. Gumus, E.; Bingol, H.; Zor, E. Nanomaterials-enriched sensors for detection of chiral pharmaceuticals. J. Pharm. Biomed. Anal. 2022, 221, 115031.
84. Suwankaisorn, B.; Aroonratsameruang, P.; Kuhn, A.; Wattanakit, C. Enantioselective recognition, synthesis, and separation of pharmaceutical compounds at chiral metallic surfaces. ChemMedChem 2024, 19, e202300557.
85. Siddiqui, S.; Ahmad, R.; Alaidarous, M.; et al. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: an integrative phytochemical and computational approach. J. Food. Biochem. 2022, 46, e14062.
86. Bhavsar, S.; Tadiparthi, R.; Gupta, S.; et al. Design and development of efficient synthetic strategies for the chiral synthesis of novel ketolide antibiotic, nafithromycin (WCK 4873). Chem. Pap. 2023, 77, 3629-40.
87. Yu, Y.; Xu, N.; Zhang, J.; Wang, B.; Xie, S.; Yuan, L. Chiral metal–organic framework d-His-ZIF-8@SiO2 core–shell microspheres used for HPLC enantioseparations. ACS. Appl. Mater. Interfaces. 2020, 12, 16903-11.
88. Hu, C.; Li, L.; Yang, N.; Zhang, Z.; Xie, S.; Yuan, L. Chiral metal-organic framework [Cu(S-mal)(bpy)]n used for separation of racemates in high performance liquid chromatography. Acta. Chim. Sinica. 2016, 74, 819-24.
89. Xie, S.; Liu, H.; Yang, J.; Ai, P.; Yuan, L. Single-handed helical framework material [{Cu(sala)}n] incorporated peramylated β-cyclodextrin for improving gas chromatography enantioseparation. Chin. J. Chromatogr. 2016, 34, 113-8.
90. Xie, S.; Hu, C.; Li, L.; et al. Homochiral metal-organic framework for HPLC separation of enantiomers. Microchem. J. 2018, 139, 487-91.
91. Yuan, B.; Li, L.; Yu, Y.; et al. Chiral metal-organic framework [Co2(d-cam)2(TMDPy)]@SiO2 core-shell microspheres for HPLC separation. Microchem. J. 2021, 161, 105815.
92. Zhang, J. H.; Nong, R. Y.; Xie, S. M.; Wang, B. J.; Ai, P.; Yuan, L. M. Homochiral metal‐organic frameworks based on amino acid ligands for HPLC separation of enantiomers. Electrophoresis 2017, 38, 2513-20.
93. Li, J.; Guo, B.; Zhang, W.; et al. Recent advances in demystifying O‐glycosylation in health and disease. Proteomics 2022, 22, e2200156.
94. Børud, B.; Koomey, M. Sweet complexity: O-linked protein glycosylation in pathogenic Neisseria. Front. Cell. Infect. Microbiol. 2024, 14, 1407863.
95. Wang, J.; Wang, X.; Li, J.; et al. A novel hydrophilic MOFs-303-functionalized magnetic probe for the highly efficient analysis of N-linked glycopeptides. J. Mater. Chem. B. 2022, 10, 2011-8.
96. Zhou, X.; Zhang, H.; Wang, L.; Wu, R. Boronic acid and fructose-1, 6-diphosphate dual-functionalized highly hydrophilic Zr-MOF for HILIC enrichment of N-linked glycopeptides. Anal. Bioanal. Chem. 2023, 415, 4767-77.
97. Mojtahedi, F.; Nasiri, M. R.; Ali, S. N.; et al. Novel chitosan-alginate dressings with UIO-66-NH2 nanoparticles and ferula gummosa extracts for effective wound healing. Colloids. Surf. A. 2025, 719, 137004.
98. Pu, C.; Zhao, H.; Hong, Y.; Zhan, Q.; Lan, M. Facile preparation of hydrophilic mesoporous metal–organic framework via synergistic etching and surface functionalization for glycopeptides analysis. Anal. Chem. 2019, 92, 1940-7.
99. Li, T.; Zeng, J.; Yang, X.; Garcia-Caparros, P.; Duan, X. The role of protein post-translational modifications in fruit ripening. Horticulturae 2024, 10, 1042.
100. Li, M.; Xiong, Y.; Qing, G. Innovative chemical tools to address analytical challenges of protein phosphorylation and glycosylation. Acc. Chem. Res. 2023, 56, 2514-25.
101. He, J.; Yu, L.; Luo, B.; Liu, Y.; Lan, F.; Wu, Y. Dielectric barrier discharge induced Oxid-Ti3C2Tx/UIO-66-NH2 composites for efficient phosphopeptides enrichment. Mater. Des. 2023, 233, 112193.
102. Du, J. L.; Fu, M. Y.; Yan, Y. H.; Ding, C. F. A complementary bimetal synergized with polyethyleneimine functionalized affinity chromatography nanosphere for enrichment of global phosphopeptides. Chin. J. Anal. Chem. 2022, 50, 55-62.
103. Pandey, M. D. Luminescent metal–organic frameworks as biosensors. Mater. Lett. 2022, 308, 131230.
104. Schofield, L. C.; Dialpuri, J. S.; Murshudov, G. N.; Agirre, J. Post-translational modifications in the Protein Data Bank. Acta. Crystallogr. D. Struct. Biol. 2024, 80, 647-60.
105. Su, M.; Hou, S. Ethylene insensitive 2 (EIN2) destiny shaper: the post-translational modification. J. Plant. Physiol. 2024, 295, 154190.
106. Wang, Y. W.; Zuo, J. C.; Chen, C.; Li, X. H. Post-translational modifications and immune responses in liver cancer. Front. Immunol. 2023, 14, 1230465.
107. Li, Y.; Zhang, R.; Hei, H. Advances in post-translational modifications of proteins and cancer immunotherapy. Front. Immunol. 2023, 14, 1229397.
108. Powell, W. C.; Jing, R.; Herlory, M.; et al. Chemical synthesis reveals pathogenic role of N-glycosylation in microtubule-associated protein tau. J. Am. Chem. Soc. 2025, 147, 6995-7007.
109. Wu, Y.; Liu, Q.; Deng, C. l-cysteine-modified metal-organic frameworks as multifunctional probes for efficient identification of N-linked glycopeptides and phosphopeptides in human crystalline lens. Anal. Chim. Acta. 2019, 1061, 110-21.
110. Xie, Y.; Deng, C. Designed synthesis of a “One for Two” hydrophilic magnetic amino-functionalized metal-organic framework for highly efficient enrichment of glycopeptides and phosphopeptides. Sci. Rep. 2017, 7, 1162.
111. Morimoto, D.; Walinda, E. A fast and simple automated multi-step protein purification method for ÄKTA go systems. Protein. Expr. Purif. 2024, 223, 106560.
112. Yang, X.; Chen, B.; Lao, Z.; Xiang, Y.; Lin, Z. A spy chemistry-based method for purification of proteins with authentic N-termini. Catalysts 2024, 14, 651.
113. Qian, L.; Liu, W.; Liu, H.; et al. Fabrication of raspberry-like cytochrome C surface-imprinted nanoparticles based on MOF composites for high-performance protein separation. ACS. Appl. Mater. Interfaces. 2021, 13, 31010-20.
114. Tan, S.; Long, Y.; Han, Q.; Guan, H.; Liang, Q.; Ding, M. Designed fabrication of polymer-mediated MOF-derived magnetic hollow carbon nanocages for specific isolation of bovine hemoglobin. ACS. Biomater. Sci. Eng. 2020, 6, 1387-96.
115. Gavara, R.; Royuela, S.; Zamora, F. A minireview on covalent organic frameworks as stationary phases in chromatography. Front. Chem. 2024, 12, 1384025.
116. Wu, Y.; Sun, N.; Deng, C. Construction of magnetic covalent organic frameworks with inherent hydrophilicity for efficiently enriching endogenous glycopeptides in human saliva. ACS. Appl. Mater. Interfaces. 2020, 12, 9814-23.
117. Zhang, X.; Feng, Q.; Xie, Z.; Xu, F.; Yan, Y.; Ding, C. A Ti/Nb-functionalized COF material based on IMAC strategy for efficient separation of phosphopeptides and phosphorylated exosomes. Anal. Bioanal. Chem. 2022, 414, 7885-95.
118. Wang, B.; Zhang, X.; Wang, B.; et al. Ti4+ functionalized β-cyclodextrin covalent organic framework as a new immobilized metal ion affinity chromatography platform for selective capture of phosphorylated peptides and exosomes. Mikrochim. Acta. 2023, 190, 399.
119. Wang, T.; Azhar, I.; Yang, Y.; et al. Fine-tuned mesoporous covalent organic frameworks for highly efficient low molecular-weight proteins separation. Nano. Res. 2022, 15, 4569-74.
120. Duong, P. H.; Kuehl, V. A.; Mastorovich, B.; Hoberg, J. O.; Parkinson, B. A.; Li-Oakey, K. D. Carboxyl-functionalized covalent organic framework as a two-dimensional nanofiller for mixed-matrix ultrafiltration membranes. J. Membr. Sci. 2019, 574, 338-48.
121. Li, H.; Zhou, Z.; Ma, T.; et al. Bonding of polyethylenimine in covalent organic frameworks for CO2 capture from air. J. Am. Chem. Soc. 2024, 146, 35486-92.
122. Chen, L.; Zhang, M.; Fu, F.; Li, J.; Lin, Z. Facile synthesis of magnetic covalent organic framework nanobeads and application to magnetic solid-phase extraction of trace estrogens from human urine. J. Chromatogr. A. 2018, 1567, 136-46.
123. Liu, J.; Su, Z.; Xu, Q.; et al. Facile synthesis of boric acid-functionalized magnetic covalent organic frameworks and application to magnetic solid-phase extraction of trace endocrine disrupting compounds from meat samples. Food. Chem. 2023, 399, 133843.
124. Li, Y.; Dong, G.; Li, J.; et al. A solid-phase microextraction fiber coating based on magnetic covalent organic framework for highly efficient extraction of triclosan and methyltriclosan in environmental water and human urine samples. Ecotoxicol. Environ. Saf. 2021, 219, 112319.
125. Xie, Z.; Yan, Y.; Tang, K.; Ding, C. F. Post-synthesis modification of covalent organic frameworks for ultrahigh enrichment of low-abundance glycopeptides from human saliva and serum. Talanta 2022, 236, 122831.
126. Lu, Y.; Du, C.; Ying, H.; et al. Facile fabrication of hydrophilic covalent organic framework composites for highly selective enrichment of N-glycopeptides. Talanta 2023, 259, 124524.
127. Ji, Y.; He, Y.; Chen, R.; et al. Hydrophilic glutathione-modified flower-like hollow covalent organic frameworks for highly efficient capture of N-linked glycopeptides. J. Mater. Chem. B. 2022, 10, 6507-13.
128. Su, P.; Li, M.; Li, X.; et al. Glutathione functionalized magnetic covalent organic frameworks with dual-hydrophilicity for highly efficient and selective enrichment of glycopeptides. J. Chromatogr. A. 2022, 1667, 462869.
129. Ma, Y. F.; Wang, L. J.; Zhou, Y. L.; Zhang, X. X. A facilely synthesized glutathione-functionalized silver nanoparticle-grafted covalent organic framework for rapid and highly efficient enrichment of N-linked glycopeptides. Nanoscale 2019, 11, 5526-34.
130. Cao, L.; Zhao, Y.; Chu, Z.; Zhang, X.; Zhang, W. Core-shell magnetic bimetallic MOF material for synergistic enrichment of phosphopeptides. Talanta 2020, 206, 120165.
131. Wang, Z. G.; Lv, N.; Bi, W. Z.; Zhang, J. L.; Ni, J. Z. Development of the affinity materials for phosphorylated proteins/peptides enrichment in phosphoproteomics analysis. ACS. Appl. Mater. Interfaces. 2015, 7, 8377-92.
132. Hu, L.; Zhou, H.; Li, Y.; et al. Profiling of endogenous serum phosphorylated peptides by titanium (IV) immobilized mesoporous silica particles enrichment and MALDI-TOFMS detection. Anal. Chem. 2009, 81, 94-104.
133. Wang, H.; Jiao, F.; Gao, F.; et al. Titanium (IV) ion-modified covalent organic frameworks for specific enrichment of phosphopeptides. Talanta 2017, 166, 133-40.
134. Gao, C.; Bai, J.; He, Y.; et al. Postsynthetic functionalization of Zr4+-immobilized core-shell structured magnetic covalent organic frameworks for selective enrichment of phosphopeptides. ACS. Appl. Mater. Interfaces. 2019, 11, 13735-41.
135. He, Y.; Huang, W.; Zheng, Q.; et al. Two-dimensional guanidinium-based covalent organic nanosheets for controllable recognition and specific enrichment of global/multi-phosphopeptides. Talanta 2021, 233, 122497.
136. Pan, Y.; Zhang, C.; Xiao, R.; Zhang, L.; Zhang, W. Dual-functionalized magnetic bimetallic metal-organic framework composite for highly specific enrichments of phosphopeptides and glycopeptides. Anal. Chim. Acta. 2021, 1158, 338412.
137. Qi, H.; Li, Z.; Ma, J.; Jia, Q. Tailoring a multifunctional magnetic cationic metal-organic framework composite for synchronous enrichment of phosphopeptides/glycopeptides. J. Mater. Chem. B. 2022, 10, 3560-6.
138. Luo, B.; Yan, S.; Zhang, Y.; Zhou, J.; Lan, F.; Wu, Y. Bifunctional magnetic covalent organic framework for simultaneous enrichment of phosphopeptides and glycopeptides. Anal. Chim. Acta. 2021, 1177, 338761.
139. Xiong, F.; Jia, J.; Ma, J.; Jia, Q. Glutathione-functionalized magnetic thioether-COFs for the simultaneous capture of urinary exosomes and enrichment of exosomal glycosylated and phosphorylated peptides. Nanoscale 2022, 14, 853-64.
140. Wu, Y.; Xu, S.; Ding, F.; Zhang, W.; Liu, H. A type of ferrocene-based derivative FE-1 COF material for glycopeptide and phosphopeptide selective enrichment. J. Funct. Biomater. 2024, 15, 185.
141. Sebastiaan Winkler, G.; Lacomis, L.; Philip, J.; Erdjument-Bromage, H.; Svejstrup, J. Q.; Tempst, P. Isolation and mass spectrometry of transcription factor complexes. Methods 2002, 26, 260-9.
142. Mosleh, I.; Khosropour, A. R.; Aljewari, H.; et al. Cationic covalent organic framework as an ion exchange material for efficient adsorptive separation of biomolecules. ACS. Appl. Mater. Interfaces. 2021, 13, 35019-25.
143. Bettada, L.; Tsai, H.; Fuh, C. B. Functional nanoparticles with magnetic 3D covalent organic framework for the specific recognition and separation of bovine serum albumin. Nanomaterials 2022, 12, 411.
144. Qiu, S.; Cai, Y.; Yao, H.; et al. Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal. Transduct. Target. Ther. 2023, 8, 132.
145. Ma, W.; Chen, H.; Hou, H.; Hu, Q.; Bai, Y. TiO2@COF-based solid-phase microextraction combined with UHPLC-MS/MS for the rapid determination of potential biomarkers of phosphatidylcholines and lysophosphatidylcholines in head and neck cancers. Anal. Bioanal. Chem. 2023, 415, 6771-83.
146. Yuan, Y.; Ren, M.; Zhu, C.; Lou, Y.; Liang, Q.; Xiong, Z. Chemoselectivity strategy based on B-label integrated with tailored COF for targeted metabolomic analysis of short-chain fatty acids by UHPLC-MS/MS. Anal. Chem. 2024, 96, 6575-83.
147. Lin, S.; Lv, Y. K.; Zhu, A.; Su, M.; Li, X.; Liang, S. X. Development of a NiFe2O4 covalent organic framework based magnetic solid-phase extraction approach for specific capture of quinolones in animal innards prior to UHPLC-Q-Orbitrap HRMS detection. Food. Chem. 2024, 454, 139796.
148. Dan, A.; Zhang, S.; Chen, Z.; et al. Facile synthesis of Cu2+-immobilized magnetic covalent organic frameworks for highly efficient enrichment and sensitive determination of five phthalate monoesters from mouse plasma with HPLC-MS/MS. Talanta 2023, 253, 123923.
149. Ma, Y.; Guo, H.; Hui, Y.; et al. Construction of Eu3+ modified covalent organic framework and fluorescence detection of L-lysine. Colloids. Surf. A. Physicochem. Eng. Asp. 2025, 718, 136969.
150. Yang, C.; Yan, B. Dual-function platform based on postsynthetic functionalization of a water-stable hydrogen-bonded organic framework: ratiometric sensing of nicotine and cotinine and dynamic anticounterfeiting for information encryption. Inorg. Chem. 2023, 62, 20458-66.
151. Mohan, B.; Singh, G.; Gupta, R. K.; et al. Hydrogen-bonded organic frameworks (HOFs): Multifunctional material on analytical monitoring. TrAC. Trends. Anal. Chem. 2024, 170, 117436.
152. Zhang, Z.; Ye, Y.; Xiang, S.; Chen, B. Exploring multifunctional hydrogen-bonded organic framework materials. Acc. Chem. Res. 2022, 55, 3752-66.
153. Zhang, Y.; Tian, M.; Majeed, Z.; et al. Application of hydrogen-bonded organic frameworks in environmental remediation: recent advances and future trends. Separations 2023, 10, 196.
154. Chen, X.; Li, N.; Lin, T.; Huang, J.; Hou, L.; Zhao, S. An off–on fluorescence sensor based on hydrogen-bonded organic frameworks for the detection of glutathione. Microchem. J. 2024, 196, 109555.
155. Chen, F.; Xu, H.; Cai, Y.; et al. Ratiometric fluorescent sensor for sensitive detection of 3-methoxytyramine based on hydrogen-bonded organic framework. J. Solid. State. Chem. 2023, 323, 124036.
156. Zhang, S.; Wen, J.; Li, H.; Chen, M. Iron modified hydrogen-bonded organic framework as fluorescent sensor for ascorbic acid detection. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 2024, 317, 124393.
157. Sahoo, R.; Mariya Tedy, A.; Manna, A. K.; Das, M. C. A water-stable hydrogen-bonded organic framework (HOF) for selective sensing of antibiotics in aqueous medium. Chemistry 2025, 31, e202404756.
158. Fan, Z.; Zheng, S.; Zhang, H.; et al. Amidinium sulfonate hydrogen-bonded organic framework with fluorescence amplification function for sensitive aniline detection. Chin. Chem. Lett. 2022, 33, 4317-20.
159. Liu, Y.; Xu, X.; Yan, B. An anthracene-based hydrogen-bonded organic framework as a bifunctional fluorescent sensor for the detection of γ-aminobutyric acid and nitrofurazone. Inorg. Chem. Front. 2022, 9, 3627-35.
160. Zhu, K.; Xu, X.; Yan, B. Eu(iii)-functionalized HOFs based on machine learning-assisted fluorescence sensing: discrimination of quinolones via PCA and BPNN models. J. Mater. Chem. C. 2022, 10, 10320-9.
161. Ahmad, A.; Imran, M.; Ahsan, H. Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases. Pharmaceutics 2023, 15, 1630.
162. Bodaghi, A.; Fattahi, N.; Ramazani, A. Biomarkers: promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon 2023, 9, e13323.
163. Xiong, F.; Zhang, T.; Ma, J.; Jia, Q. Dual-ligand hydrogen-bonded organic framework: Tailored for mono-phosphopeptides and glycopeptides analysis. Talanta 2024, 266, 125068.
164. Tang, J.; Liu, J.; Zheng, Q.; et al. In-situ encapsulation of protein into nanoscale hydrogen-bonded organic frameworks for intracellular biocatalysis. Angew. Chem. Int. Ed. Engl. 2021, 60, 22315-21.
165. Chen, X.; Zheng, Q.; Cai, W.; Sheng, J.; Wang, M. Biodegradable hydrogen-bonded organic framework for cytosolic protein delivery. ACS. Appl. Mater. Interfaces. 2023, 15, 54346-52.
166. Li, H. Y.; Zhang, S. Q.; Chen, M. L.; Wang, J. H. Lumi-HOF@Tb as probes for multiple ratiometric fluorescence and chemiluminescence sensing of α-glucosidase. Anal. Chem. 2022, 94, 15448-55.
167. Liang, W.; Carraro, F.; Solomon, M. B.; et al. Enzyme encapsulation in a porous hydrogen-bonded organic framework. J. Am. Chem. Soc. 2019, 141, 14298-305.
168. Li, W.; Shi, J.; Chen, Y.; et al. Nano-sized mesoporous hydrogen-bonded organic frameworks for in situ enzyme immobilization. Chem. Eng. J. 2023, 468, 143609.
169. Eliwa, A. S.; Medany, S. S.; Mohamed, G. G.; Hefnawy, M. A. Nickel metal-organic framework-based surfaces for effective supercapacitor application. J. Inorg. Organomet. Polym. 2025, 35, 4797-809.
170. Copeman, C.; Bicalho, H. A.; Terban, M. W.; et al. Adsorptive removal of iodate oxyanions from water using a Zr-based metal-organic framework. Chem. Commun. 2023, 59, 3071-4.
171. Shah, A. H.; Abideen, Z. U.; Maqsood, S.; et al. Porous Cu-based metal organic framework (Cu-MOF) for highly selective adsorption of organic pollutants. J. Solid. State. Chem. 2023, 322, 123935.
172. Huang, J.; Zhang, X.; Huang, J.; Zheng, D.; Xu, M.; Gu, Z. MOF-based materials for electrochemical reduction of carbon dioxide. Coord. Chem. Rev. 2023, 494, 215333.
173. Ramakrishnan, A.; Rathod, S.; Tucho, W. M.; Chavan, S. M.; Yu, Z. MOF-808 as effective support for Cu-based catalyst for CO2 hydrogenation to methanol. Catalysts 2025, 15, 324.
174. Chen, J.; Tang, Z.; Zhu, D.; et al. Charge-induced defective MOF-801 with enhanced sorption heat for efficient hydrogen storage. Small 2025, 21, e2502860.
175. Zhu, X.; He, T.; Song, X.; et al. Large-area metal-organic framework glasses for efficient X-ray detection. Adv. Mater. 2024, 36, e2412432.
176. Abdelmigeed, M. O.; Ahmad Ebrahim, M. Z.; Rahmanian, V.; et al. Mechanically robust mesoporous UiO-66-NH2/nanofibrous aerogel for organophosphonates detoxification. Adv. Sci. 2025, 12, e2416540.
177. Xiao, J.; Cong, M.; Li, M.; et al. Self‐assembled nanoporous metal–organic framework monolayer film for osmotic energy harvesting. Adv. Funct. Mater. 2024, 34, 2307996.
178. Singh, R.; Ahn, Y. H. Chapter 2 - Separation science in modern era. In Advances in separation sciences. Ingole, P.G., Hussain, C.M., Eds.; Elsevier: 2025; pp. 19-36.
179. Wang, D.; Zhang, Y.; Dong, H.; Chen, H.; Sengupta, A. Ion exchange enabled selective separation from decontamination to desalination to decarbonization: recent advances and opportunities. Environ. Sci. Water. Res. Technol. 2024, 10, 1319-34.
180. Seyhan, A. A.; Carini, C. Are innovation and new technologies in precision medicine paving a new era in patients centric care? J. Transl. Med. 2019, 17, 114.
181. Han, G. R.; Goncharov, A.; Eryilmaz, M.; et al. Machine learning in point-of-care testing: innovations, challenges, and opportunities. Nat. Commun. 2025, 16, 3165.
Cite This Article
How to Cite
Download Citation
Export Citation File:
Type of Import
Tips on Downloading Citation
Citation Manager File Format
Type of Import
Direct Import: When the Direct Import option is selected (the default state), a dialogue box will give you the option to Save or Open the downloaded citation data. Choosing Open will either launch your citation manager or give you a choice of applications with which to use the metadata. The Save option saves the file locally for later use.
Indirect Import: When the Indirect Import option is selected, the metadata is displayed and may be copied and pasted as needed.
About This Article
Copyright
Data & Comments
Data






























Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.